醫師學術論文
Paper吳錫金 Hsi-Chin Wu 院長(中國醫藥大學北港附設醫院)
吳錫金教授專精於泌尿腫瘤–攝護腺癌、腎臟癌、泌尿上皮癌、睪丸癌及陰莖癌的診斷與治療,是泌尿科醫學會泌尿腫瘤委員會成員,亦參與國衛院台灣癌症臨床研究合作組織攝護腺癌臨床指引編撰。於 2008 及 2012 分別前往加州大學爾灣分校附設醫院及佛羅里達州 Celebration 醫院進修機器手臂手術;亦專精於微創手術包括冷凍治療及高頻率集中超音波治療 (HIFU),提供病人個人化的治療
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 張景欣(Ching-Hsin Chang)、余秉軒(Ping-Hsuan Yu)、謝博帆(Hsieh, Po-Fan)、洪健華(Jian-Hua Hong)、蔣智宏(Chih-Hung Chiang)、鄭浩民(Hao-Min Cheng)、吳錫金(Hsi-Chin Wu)、黃昭淵(Chao-Yuan Huang)、林子平(Tzu-Ping Lin)*,Prostate health index density aids the diagnosis of prostate cancer detected using magnetic resonance imaging targeted prostate biopsy in Taiwanese multicenter study,Journal of the Chinese Medical Association,2024 Jul,87():678-685 | 2024 . 07 |
2 | 王又德(Yu-De Wang)、黃志平(Chi-Ping Huang)、楊有容(You-Rong Yang)、吳錫金(Hsi-Chin Wu)、徐右儒(HSU YU-JU)、葉依純(Yi-Chun, Yeh)、葉佩純(Pei-Chun,Yeh)、吳國禎(Kuo-Chen Wu)、高嘉鴻(Chia-Hung Kao)*,Machine Learning and Radiomics of Bone Scintigraphy: Their Role in Predicting Recurrence of Localized or Locally Advanced Prostate Cancer,Diagnostics,2023 Nov,13(21):3380 | 2023 . 11 |
3 | 謝登富(Teng-Fu Hsieh)、陳鴻霖(CHEN HUNG-LIN)、夏瑩芳(Ying-Fang Hsia)、林則成(Che-Chen Lin)、姜秀穎(Hsiu-Yin Chiang)、巫旻諺(WU MIN-YEN)、陳聖軒(CHEN SHENG-HSUAN)、謝博帆(Hsieh, Po-Fan)、吳錫金(Hsi-Chin Wu)、張菡(Han Chang)*、郭錦輯(Kuo, Chin-Chi)*,Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation,BioMedicine,2023 Sep,13(3):9-24 | 2023 . 09 |
4 | 曾浩翔(CHEN HAO XIANG)、蔡禮賢(Li-Hsien,Tsai)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、葉士芃(Shih-Peng Yeh)、連啟舜(Chi-Shun Lien)、楊啟瑞(Chi-Rei Yang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、謝博帆(Hsieh, Po-Fan)*、黃志平(Chi-Ping Huang)*,Enzalutamide prior to radium-223 is associated with better overall survival in metastatic castration-resistant prostate cancer patients compared to abiraterone - a retrospective study,Cancers,2023 Jul,15(13):3516-3516 | 2023 . 07 |
5 | 謝博帆(Hsieh, Po-Fan)、李柏毅(LI PO-I)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、黃志平(Chi-Ping Huang)*,Learning Curve of Transperineal MRI/US Fusion Prostate Biopsy: 4-Year Experience,Life-Basel,2023 Feb,13():638 | 2023 . 02 |
6 | (Cheng-Hsi Liao)、張文馨(Wen-Shin Chang)、許瑋麟(Wei-Lin Hsu)、(Pei-Shin Hu)、吳錫金(Hsi-Chin Wu)、(Shih-Wei Hsu)、(Bo-Ren Wang)、(Te-Cheng Yueh)、陳肇烜(Chao-Hsuan Chen)、夏德椿(Te-Chun Hsia)、黃文欽(Huang,Wen-Chin)*、包大靝(Da-Tian Bau)*、蔡佳紋(Chia-Wen Tsai)*,Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk,ANTICANCER RESEARCH,2023 Jan,43(1):381-387 | 2023 . 01 |
7 | 李柏翰(Po Han, Li)、(Cheng-Hsi Liao)、黃文欽(Huang,Wen-Chin)、張文馨(Wen-Shin Chang)、吳錫金(Hsi-Chin Wu)、(Shih-Wei Hsu)、(Kai-Yuan Chen)、(Zhi-Hong Wang)、夏德椿(Te-Chun Hsia)、包大靝(Da-Tian Bau)*、蔡佳紋(Chia-Wen Tsai)*,Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk,ANTICANCER RESEARCH,2023 Jan,43(1):343-349 | 2023 . 01 |
8 | (An-Chen Chang)、林良蔚(Lin, Liang-Wei)、(Yen-Chen Chen)、陳均(Po-Chun Chen)、劉軒誌(Shan-Chi Liu)、(Huai-Ching Tai)、吳錫金(Hsi-Chin Wu)、(Shian-Ying Sung)、(Tien-Huang Lin)*、湯智昕(Chih-Hsin Tang)*,The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis,International Journal of Biological Sciences,2023 Jan,19(3):760-771 | 2023 . 01 |
9 | (Tien-Huang Lin)、張瓈云(Sunny LY Chang)、(Pham Minh Khanh)、(Nguyen Thi Nha Trang)、劉軒誌(Shan-Chi Liu)、蔡筱琪、(An-Chen Chang)、林若瑜(Lin, Jo-Yu)、(Po-Chun Chen)、(Ju-Fang Liu)、郭政宏(Jeng-Hung Guo)、劉俊麟(Chun-Lin Liu)、吳錫金(Hsi-Chin Wu)*、湯智昕(Chih-Hsin Tang)*,Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression,Cells,2022 Oct,11(20):3285 | 2022 . 10 |
10 | 劉軒誌(Shan-Chi Liu)、(Hung-Lun Hsieh)、蔡俊灝(Chun-Hao Tsai)、馮逸卿(Yi-Ching Fong)、柯智淵(Chih-Yuan KO)、吳錫金(Hsi-Chin Wu)、張瓈云(Sunny LY Chang)、許晉榮(Chin-Jung Hsu)、湯智昕(Chih-Hsin Tang)*,CCN2 Facilitates IL-17 Production and Osteoclastogenesis in Human Osteoarthritis Synovial Fibroblasts by Inhibiting miR-655 Expression,JOURNAL OF BONE AND MINERAL RESEARCH,2022 Aug,(): | 2022 . 08 |
11 | 謝博帆(Hsieh, Po-Fan)、張天佑(Tian-Yu Jhang)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、吳錫金(Hsi-Chin Wu)*,Saturation Target Biopsy can Overcome the Learning Curve of Magnetic Resonance Imaging/Ultrasound Fusion Biopsy of the Prostate,Journal of Mens Health,2022 May,18(6):127 | 2022 . 05 |
12 | (Huai-Ching Tai)、(Shih-Wei Wang)、Sanskruti Sw(Sanskruti Swain)、林良蔚(Lin, Liang-Wei)、蔡俊灝(Chun-Hao Tsai)、劉軒誌(Shan-Chi Liu)、吳錫金(Hsi-Chin Wu)、郭政宏(Jeng-Hung Guo)、劉俊麟(Chun-Lin Liu)、(Yu-Wei Lai)、(Tien-Huang Lin)、(Shun-Fa Yang)*、湯智昕(Chih-Hsin Tang)*,Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α2β1 expression,JOURNAL OF PINEAL RESEARCH,2022 Apr,72(3):e12793 | 2022 . 04 |
13 | 謝博帆(Hsieh, Po-Fan)、張天佑(Tian-Yu Jhang)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、王又德(Yu-De Wang)、黃文欽(Huang,Wen-Chin)*、吳錫金(Hsi-Chin Wu)*,A comparative study of transperineal software-assisted magnetic resonance/ ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate,BMC Urology,2022 Apr,22():72 | 2022 . 04 |
14 | 劉軒誌(Shan-Chi Liu)、蔡俊灝(Chun-Hao Tsai)、王俞涵(Wang, Yu-Han)、蘇振銘(Su, Chen-Ming)、吳錫金(Hsi-Chin Wu)、馮逸卿(Yi-Ching Fong)、(Shun-Fa Yang)*、湯智昕(Chih-Hsin Tang)*,Melatonin abolished proinflammatory factor expression and antagonized osteoarthritis progression in vivo,Cell Death & Disease,2022 Mar,13(3):215 | 2022 . 03 |
15 | 林俊佑(Chung-Yu Lin)、翁涵育(Han-Yu Weng)、戴大堯(Ta-Yao Tai)、吳錫金(Hsi-Chin Wu)、陳汶吉(Wen-Chi Chen)、陳忠信(Chung-Hsin Chen)、黃昭淵(Chao-Yuan Huang)、羅啟文(Chi-Wen Lo)、蔡宗佑(Chung-You Tsai)、吳維哲(Wei-Che Wu)、江元宏(Yuan-Hong Jiang)、李宇坤(Yu-Khun Lee)、薛又仁(Thomas Y. Hsueh)、邱文祥(Allen W. Chiu)、江秉鈞(Bing-Juin Chiang)、黃旭志(Hsu-Che Huang)、陳盈伸(I-Hsuan Alan Chen)、陳永泰(Yung-Tai Chen)、林威宇(Wei-Yu Lin)、吳佳璋(Chia-Chang Wu)、蔡曜州(Yao-Chou Tsai)、李香瑩(Hsiang-Ying Lee)、李威明(Wei-Ming Li)*,Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group,Journal of Personalized Medicine,2022 Feb,12(2):2 | 2022 . 02 |
16 | 謝博帆(Hsieh, Po-Fan)、李宗叡(LI TZUNG-RUEI)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、葉進仲(Chin-Chung Yeh)、黃文欽(Huang,Wen-Chin)、吳錫金(Hsi-Chin Wu)*,Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer,BMC Urology,2021 Nov,21():161 | 2021 . 11 |
17 | (Cheng-Hsi Liao)、蔡佳紋(Chia-Wen Tsai)、(Wen-Shin Chang)、(Zhi-Hong Wang)、龔志力(Gong Chi-Li)、吳錫金(Hsi-Chin Wu)、(Bo-Ren Wang)、(Shih-Wei Hsu)、黃文欽(Huang,Wen-Chin)、沈德群(Shen, Te-Chun)、包大靝(Da-Tian Bau)*,Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk,IN VIVO,2021 Sep,35(5):2535-2540 | 2021 . 09 |
18 | (Po-Chun Chen)、劉軒誌(Shan-Chi Liu)、(Tien-Huang Lin)、林良蔚(Lin, Liang-Wei)、吳錫金(Hsi-Chin Wu)、(Huai-Ching Tai)、(Shih-Wei Wang)、湯智昕(Chih-Hsin Tang)*,Prostate cancer-secreted CCN3 uses the GSK3β and β-catenin pathways to enhance osteogenic factor levels in osteoblasts,ENVIRONMENTAL TOXICOLOGY,2021 Mar,36(3):425-432 | 2021 . 03 |
19 | 許儷絹(Li-Chuan Hsu)*、田意民(Yi-Min Tien)、黃榮村(Jung-Tsun Huang)、林佳瑤(Lin, Chia-Yao)、吳錫金(Hsi-Chin Wu)、林嘉德(Chia-Der Lin)、蔡崇豪(Chon-Haw Tsai),Emotional sensitivity predicts internship performance of medical students enrolled under different admission screening protocols,MEDICAL TEACHER,2020 Dec,42(12):1354-1361 | 2020 . 12 |
20 | 黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、王又平(Yu-Ping Wang)、王又德(Yu-De Wang)*,External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomy,BMC Urology,2020 Sep,20(1):146 | 2020 . 09 |
21 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、黃志平(Chi-Ping Huang)、吳錫金(Hsi-Chin Wu)、謝博帆(Po-Fan Hsieh)*、鄒頡龍(Chieh-Lung Chou)*,A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients,Toxins,2020 Jun,12(6):365-365 | 2020 . 06 |
22 | (Tsung-Jung Ho)、吳錫金(Hsi-Chin Wu)、(V. Bharath Kumar)、郭薇雯(Wei-Wen Kuo)、翁悅珊(Yueh-Shan Weng)、(Yu-Lan Yeh)、(B. Mahalakshmi)、(Cecilia Hsuan Day)、(Chi-Cheng Li)*、黃志揚(Chih-Yang Huang)*,Danshen (Salvia miltiorhiza) inhibits Leu27 IGF-11-induced hypertrophy in H9c2 cells,ENVIRONMENTAL TOXICOLOGY,2020 Apr,(): | 2020 . 04 |
23 | (Meng Chen)、張文馨(Wen-Shin Chang)、沈德群(Te-Chun Shen)、龔志力(Gong Chi-Li)、林孟亮、(Zhi-Hong Wang)、王韻琪(Wang, Yun-Chi)、陳肇烜(Chao-Hsuan Chen)、吳錫金(Hsi-Chin Wu)、包大靝(Da-Tian Bau)*、蔡佳紋(Chia-Wen, Tsai)*,Association of Nijmegen Breakage Syndrome 1 Genotypes With Bladder Cancer Risk,ANTICANCER RESEARCH,2020 Apr,40(4):2011-2017 | 2020 . 04 |
24 | 張文馨(Wen-Shin Chang)、沈德群(Te-Chun Shen)、(Jiuan-Miaw Liao)、蔡岳廷(Tsai, Yueh-Ting)、夏德椿(Te-Chun Hsia)、吳錫金(Hsi-Chin Wu)、蔡佳紋(Chia-Wen, Tsai)*、包大靝(Da-Tian Bau)*,Significant Contribution of DNA Repair Human 8-Oxoguanine DNA N-Glycosylase 1 Genotypes to Renal Cell Carcinoma,OncoTargets and Therapy,2020 Feb,13():1583-1591 | 2020 . 02 |
25 | (Cheng-Hsi Liao)、(Wen-Shin Chang)、(Jiuan-Miaw Liao)、吳錫金(Hsi-Chin Wu)、沈德群(Te-Chun Shen)、楊家欣(Jai-Sing Yang)、蔡輔仁(Fuu-Jen Tsai)、蔡佳紋(Chia-Wen, Tsai)、余建志*、包大靝(Da-Tian Bau)*,The Role of Genotype/Phenotype at Apurinic/Apyrimidinic Endonuclease Rs1130409 in Renal Cell Carcinoma,CHINESE JOURNAL OF PHYSIOLOGY,2020 Jan,63(1):43-49 | 2020 . 01 |
26 | 王士豪(Shih-Hao Wang)、吳錫金(Hsi-Chin Wu)、(Khan Farheen Badrealam)、郭悅雄(Yueh-Hsiung Kuo)、(Yun-Peng Chao)、許希賢(Hsi-Hsien Hsu)、包大靝(Da-Tian Bau)、(Vijaya Padma Viswanadha)、(Yi-Hui Chen)、(Pei-Jei Lio)、姜中人*、黃志揚(Chih-Yang Huang)*,Taiwanin E Induces Cell Cycle Arrest and Apoptosis in Arecoline/4-NQO-Induced Oral Cancer Cells Through Modulation of the ERK Signaling Pathway,Frontiers in Oncology,2019 Dec,(): | 2019 . 12 |
27 | 黃士殷(Shih-Yin Huang)、黃冠中、謝博帆(Po-Fan Hsieh)、吳錫金(Hsi-Chin Wu)、黃文欽(Huang,Wen-Chin)*,Osajin displays potential anti-prostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression,PROSTATE,2019 Sep,79(13):1543-1552 | 2019 . 09 |
28 | 謝博帆(Po-Fan Hsieh)、李瑋涓(Li, Wei-Juan)、林維卿(Wei-Ching Lin)、張菡(Han Chang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、楊啟瑞(Chi-Rei Yang)、陳汶吉(Wen-Chi Chen)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Combining Prostate Health Index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population,WORLD JOURNAL OF UROLOGY,2019 Aug,.(.):.-. | 2019 . 08 |
29 | 王又德(Yu-De Wang)、黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、王又平(Yu-Ping Wang)、謝博帆(Po-Fan Hsieh)*,The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting ipsilateral renal function after partial nephrectomy,BMC Urology,2019 Aug,19(1):72 | 2019 . 08 |
30 | 張文馨(Wen-Shin Chang)、沈德群(Te-Chun Shen)、葉威蘭(Yeh, Wei-Lan)、余建志、林慧怡(Lin, Hui-Yi)、吳錫金(Hsi-Chin Wu)、蔡佳紋(Chia-Wen, Tsai)*、包大靝(Da-Tian Bau)*,Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2019 Mar,20(7):1563 | 2019 . 03 |
31 | 林詩怡(Shih-Yi Lin)、林橙莉(Cheng-Li Lin)、宋鴻樟(Fung-Chung J Sung)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、陳汶吉(Wen-Chi Chen)、王怡寬(I-Kuan Wang)、陳朝榮(Chao-Jung Chen)*、周安國(An-Kuo Chou)、高嘉鴻(Chia-Hung Kao)*,Risk of subsequent health disorders among living kidney donors,MEDICINE,2019 Feb,98(7):e14494 | 2019 . 02 |
32 | 黃士殷、黃冠中、吳錫金(Hsi-Chin Wu)、高銘欽(Ming-Ching Kao)、黃文欽(Huang,Wen-Chin)*,Ganoderma tsugae Inhibits the SREBP-1/AR Axis Leading to Suppression of Cell Growth and Activation of Apoptosis in Prostate Cancer Cells,MOLECULES,2018 Oct,23(10):2539 | 2018 . 10 |
33 | (Tsung-Hsun Tsai)、(Yao-Ming Wang)、(Wen-Shin Chang)、蔡佳紋(Chia-Wen, Tsai)、吳錫金(Hsi-Chin Wu)、(Huai-Mei Hsu)、(Yun-Chi Wang)、(Hsin-Ting Li)、龔志力*、包大靝(Da-Tian Bau)*、李繼源(Chi-Yuan Li)*,Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer,ANTICANCER RESEARCH,2018 Sep,38(9):5159-5164 | 2018 . 09 |
34 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、黃志平(Chi-Ping Huang)、陳汶吉(Wen-Chi Chen)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、連啟舜(Chi-Shun Lien)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4e10 ng/mL,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2018 Aug,34():461-466 | 2018 . 08 |
35 | (CHENG-HSI LIAO)、吳錫金(Wu, Hsi-Chin)、(PEI-SHIN HU)、(SHIH-WEI HSU)、沈德群(Te-Chun Shen)、夏德椿(Hsia, Te-Chun)、(WEN-SHIN CHANG)*、蔡佳紋(Tsai, Chia-Wen)*、包大靝(Bau, Da-Tian)*,The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients,ANTICANCER RESEARCH,2018 Jul,38(7):3907-3912 | 2018 . 07 |
36 | 劉耀隆(Yao-Lung Liu)、林冠合(Lin, Kuan-Ho)、(Shanmugam Tamilselvi)、陳維恭(Chen, Wei-Kung)、(Chia-Yao Shen)、(Ray-Jade Chen)、戴瑄(Cecilia Hsuan Day)、吳錫金(Wu, Hsi-Chin)、(Vijaya Padma Viswanadha)、黃志揚(Huang, Chih-Yang)*,Elevated Phosphate Levels Trigger Autophagy-Mediated Cellular Apoptosis in H9c2 Cardiomyoblasts,CardioRenal Medicine,2018 Jan,8(1):31-40 | 2018 . 01 |
37 | 林詩怡(Lin, Shih-Yi)、林橙莉、張兆祥(Chang, Chao-Hsiang)、吳錫金(Wu, Hsi-Chin)、陳汶吉(Chen, Wen-Chi)、王怡寬(Wang, I-Kuan)、劉耀隆(Yao-Lung Liu)、宋鴻樟(Sung, Fung-Chang)、(Yen?Jung Chang)、高嘉鴻(Kao, Chia-Hung)*,Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study,Urolithiasis,2017 Oct,45(5):465-472 | 2017 . 10 |
38 | 張兆祥(Chang, Chao-Hsiang)、邱鴻傑(Hung-Chieh Chiu)、林維卿(Lin, Wei-Ching)、何子龍(Tzu-Lung Ho)、張菡(Chang, Han)、張議徽(Yi-Huei Chang)、黃志平(Huang, Chi-Ping)、吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、謝博帆(Po-Fan Hsieh)*,The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy,Biomed Research International,2017 Oct,2017():1-6 | 2017 . 10 |
39 | 林詩怡(Lin, Shih-Yi)、林橙莉、張兆祥(Chang, Chao-Hsiang)、吳錫金(Wu, Hsi-Chin)、林志學(Lin, Chih-Hsueh)、高嘉鴻(Kao, Chia-Hung)*,Risk of age-related macular degeneration in patients with prostate cancer: a nationwide, population-based cohort study.,ANNALS OF ONCOLOGY,2017 Oct,28(10):2575-2580 | 2017 . 10 |
40 | 吳錫金(Wu,Hsi-Chin)、賴英秀(Lay Ing Shiow)、徐布、何宗融(Tsung-Jung Ho)、(Shiu-Min Cheng)、(Chih-Hao Lin)、(Tran Duc Dung)、鄭隆賓(Long-Bin Jeng)、(Vijaya Padma Viswanadha)、黃志揚(Chih-Yang Huang)*,Zanthoxylum avicennae extract enhances GSK-3b to attenuate b-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice,ENVIRONMENTAL TOXICOLOGY,2017 Sep,32(9):2133-2143 | 2017 . 09 |
41 | (Wei-Yu Lin)、(Ying-Hsu Chang)、林橙莉、高嘉鴻(Chia-Hung Kao)、吳錫金(Wu,Hsi-Chin)*,Erectile dysfunction and the risk of prostate cancer,Oncotarget,2017 Aug,8(32):52690-52698 | 2017 . 08 |
42 | 王又德(Yu-De Wang)、張兆祥(Chao-Hsiang Chang)、黃志平(Chi-Ping Huang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、謝博帆(Po-Fan Hsieh)*,New-generation nephrometry systems: head-to-head comparison of tumor contact surface area and resected and ischemic volume,Urological Science,2017 Aug,28():84-88 | 2017 . 08 |
43 | (CHENG-HSI LIAO)、張文馨(Chang, Wen-Shin)、(PEI-SHIN HU)、吳錫金(Wu,Hsi-Chin)、(SHIH-WEI HSU)、劉彥芳(Yen-Fang Liu)、劉詩平(Shih-Ping Liu)、洪慧珊(Huey-Shan Hung)、包大靝(Da-Tian Bau)*、蔡佳紋(Tsai, Chia-Wen)*,The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma,IN VIVO,2017 Jul,31(3):631-635 | 2017 . 07 |
44 | 林詩怡(Shih-Yi Lin)、林橙莉、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、王怡寬(I-Kuan Wang)、周哲毅(Che-Yi Chou)、梁基安(Ji-An Liang)*,Risk of acute myocardial infarction in upper tract urothelial carcinoma patients receiving radical nephroureterectomy: a population-based cohort study,Oncotarget,2017 Jun,(): | 2017 . 06 |
45 | (Wei-Yu Lin)、(Karl-Erik Andersson)、林橙莉、高嘉鴻(Chia-Hung Kao)、吳錫金(Wu,Hsi-Chin)*,Association of lower urinary tract syndrome with peripheral arterial occlusive disease,PLoS One,2017 Mar,12(3):e0170288 | 2017 . 03 |
46 | 黃煒軒(Wei-Hsuan Huaug)、張兆祥(Chang, Chao-Hsiang)、黃志平(Huang, Chi-Ping)、吳錫金(Wu, Hsi-Chin)、謝博帆(Po-Fan Hsieh)*,The percentage of resected and ischemic volume determined by a geometric model is a significant predictor of renal functional change after partial nephrectomy,International Braz J Urol,2017 Jan,43(1):80-86 | 2017 . 01 |
47 | 黃志揚(Chih-Yang Huang)、(Show-Yih Liou)、郭薇雯(Wei-Wen Kuo)、吳錫金(Wu,Hsi-Chin)、(Yen-Lin Chang)、陳冬生(Tung-Sheng Chen)*,Chemiluminescence analysis of antioxidant capacity for serum albumin isolated from healthy or uremic volunteers,LUMINESCENCE,2016 Dec,31(8):1474-1478 | 2016 . 12 |
48 | 蕭子玄(SIU JUSTIN JI-YUEN)、楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)*,Salvage prostate cryoablation for recurrent localized prostate cancer after radiotherapy,Urological Science,2016 Dec,(): | 2016 . 12 |
49 | 林冠合(Kuan-Ho Lin)、(Chien-Liang Liu)、郭薇雯(Wei-Wen Kuo)、(Catherine Reena Pau)、陳維恭(Wei-Kung Chen)、(Su-Ying Wen)、(Cecilia Hsuan Day)、吳錫金(Wu,Hsi-Chin)、(Vijaya Padma Viswanadha)、黃志揚(Chih-Yang Huang)*,Early Fluid Resuscitation by Lactated Ringer's Solution Alleviate the Cardiac Apoptosis in Rats with Trauma-Hemorrhagic Shock,PLoS One,2016 Dec,11(10):e0165406 | 2016 . 12 |
50 | 林詩怡(Shih-Yi Lin)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、林精湛(Ching-Chan Lin)、張凱博(Kai-Po Chang)、黃志平(Chi-Ping Huang)、徐武輝(Wu-Huei Hsu)、張志宗(Chiz-Tzung Chang)、陳朝榮(Chao-Jung Chen)*,Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma,Scientific Reports,2016 Sep,6():34446 | 2016 . 09 |
51 | 張文馨(WEN-SHIN CHANG)、廖丞晞(CHENG-HSI LIAO)、蔡佳紋(Tsai, Chia-Wen)、(PEI-SHIN HU)、吳錫金(Wu,Hsi-Chin)、許師偉(SHIH-WEI HSU)、蕭捷倫(CHIEH-LUN HSIAO)、(CHANG-HSIEN HSU)、(YI-WEN HUNG)、包大靝(Da-Tian Bau)*,Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan,ANTICANCER RESEARCH,2016 Sep,36(9):4509-4514 | 2016 . 09 |
52 | 謝博帆(Po-Fan Hsieh)、王又德(Yu-De Wang)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、陳冠亨(Guang-Heng Chen)、張兆祥(Chang,Chao-Hsiang)*,A Mathematical Method to Calculate Tumor Contact Surface Area: An Effective Parameter to Predict Renal Function after Partial Nephrectomy,JOURNAL OF UROLOGY,2016 Jul,196(1):33-39 | 2016 . 07 |
53 | 張文馨(WEN-SHIN CHANG)、廖丞晞(CHENG-HSI LIAO)、蔡佳紋(Tsai, Chia-Wen)、(PEI-SHIN HU)、吳錫金(Wu,Hsi-Chin)、(SHIH-WEI HSU)、(HONG-XUE JI)、(CHIEH-LUN HSIAO)、包大靝(Da-Tian Bau)*,The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma,ANTICANCER RESEARCH,2016 May,36(5):2205-2210 | 2016 . 05 |
54 | 蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)*,Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients,RENAL FAILURE,2016 Mar,38(5):663-670 | 2016 . 03 |
55 | (Wei-Ting Kuo)、(Yuan-Chung Tsai)、吳錫金(Wu,Hsi-Chin)、何永仁(Yung-Jen Ho)、陳悦生(Yueh-Sheng Chen)、(Chen-Han Yao)、姚俊旭(Chun-Hsu Yao)*,Radiosensitization of Non-Small Cell Lung Cancer by Kaempferol,ONCOLOGY REPORTS,2015 Nov,34(5):2351-2356 | 2015 . 11 |
56 | 陳冬生*、劉紹毅(Show-Yih Liou)、郭薇雯(Wei-Wen Kuo)、吳錫金(Wu,Hsi-Chin)、鍾國屏(Gwo-Ping Jong)、王雪芳(Hsueh-Fang Wang)、沈賈堯(Chia-Yao Shen)、V. Vijaya Pa(V. Vijaya Padma)、黃志揚(Chih-Yang Huang)*、張炎林(Yen-Lin Chang)*,Rapid method for the quantification of hydroquinone concentration: chemiluminescent analysis,LUMINESCENCE,2015 Nov,30(7):947-949 | 2015 . 11 |
57 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)*,The value of cystography in the prediction of early urinary continence after radical prostatectomy,Urological Science,2015 Aug,(): | 2015 . 08 |
58 | 張文馨(Wen-Shin Chang)、廖丞晞(Cheng-Hsi Liao)、許欽木(Chin-Mu Hsu)、(Chung-Yu Huang)、蔡佳紋(Chia-Wen Tsai)、吳錫金(Wu,Hsi-Chin)、(Pei-Shin Hu)、(Tzu-Chia Wang)、(Yun-Ru Syu)、(Hao-Ai Shui)、包大靝(Da-Tian Bau)*,Significant Association of Cyclooxygenase 2 Genotypes with Upper Tract Urothelial Cancer,ANTICANCER RESEARCH,2015 May,35(5):2725-2730 | 2015 . 05 |
59 | 白培英(Pei-Ying Pai)、謝嘉容(Vivian Chia-Rong Hsieh)、(Chang-Bi Wang)、吳錫金(Wu,Hsi-Chin)、梁文敏(Wen-Miin Liang)、(Yu-Jun Chang)、吳聰能*,Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis.,International Journal of Cardiology,2015 May,193():1-7 | 2015 . 05 |
60 | 謝承紘(Cheng-Hong Hsieh)、(Tien-Huang Lin)、謝宥諒(You-Liang Hsieh)、(Chia-Yao Shen)、郭盛助(Sheng-Chu Kuo)、吳錫金(Wu,Hsi-Chin)、(Wen-Shin Chien)、(Dennis Jine-Yuan Hsieh)、(Su-Ying Wen)、(Wei-Jen Ting)、姚俊旭(Chun-Hsu Yao)*、黃志揚(Chih-Yang Huang)*,Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatment,ENVIRONMENTAL TOXICOLOGY,2015 Mar,95(4):799-808 | 2015 . 03 |
61 | (Hsun-Nan Kuo)、黃志揚(Chih-Yang Huang)、(Yueh-Min Lin)、(Li-Chin Chung)、(Ray-Jade Chen)、(Chao Hung Lai)、吳錫金(Wu,Hsi-Chin)、(Chia-Yao Shen)、(Cecilia Hsuan Day)、陳冬生*,Adaptation to Oxidative Stress in Uremic Patients with Hemodialysis:Role of Functional Foods,Adaptive Medicine,2015 ,7(3):111-116 | 2015 . |
62 | 張文馨(WEN-SHIN CHANG)、廖丞晞(CHENG-HSI LIAO)、繆佳恩(CHIA-EN MIAO)、吳錫金(Wu,Hsi-Chin)、侯琳琳(LIN-LIN HOU)、蕭捷倫(CHIEH-LUN HSIAO)、紀宏學(HONG-XUE JI)、蔡佳紋(CHIA-WEN TSAI)、包大靝(Da-Tian Bau)*,The Role of Functional Polymorphisms of Cyclooxygenase 2 in Renal Cell Carcinoma,ANTICANCER RESEARCH,2014 Oct,34(10):5481-5486 | 2014 . 10 |
63 | 林建甫(Jeff Chien-Fu Lin)*、(Cheng-Chun Wu)、(Chi Lo)*、梁文敏(Wen-Miin Liang)、(Chi-Fung Cheng)、(Chang-Bi Wang)、(Yu-Jun Chang)、吳錫金(Wu,Hsi-Chin)、(Tsai-Hsueh Leu),Mortality and complications of hip fracture in young adults: a nationwide population-based cohort study,BMC MUSCULOSKELETAL DISORDERS,2014 Oct,15(362): | 2014 . 10 |
64 | 張文馨(Wen-Shin Chang)、蔡佳紋(Tsai, Chia-Wen)、王舒民(Shu-Ming Wang)、王錫五(Shyi-Wu Wang)、吳錫金(Wu,Hsi-Chin)、紀宏學(Hong-Xue Ji)、林志學(Chih-Hsueh Lin)、王智弘(Zhi-Hong Wang)、周柔君(Jou-Chun Chou)、包大靝(Da-Tian Bau)*、王錫崗(Wang, Paulus Shyi-Gang)*,Association of Caveolin-1 Genotypes with Renal Cell Carcinoma Risk in Taiwan,CHINESE JOURNAL OF PHYSIOLOGY,2014 Aug,57(4):220-226 | 2014 . 08 |
65 | 徐金雲(Claudia Chin Yun Hsu)、陳緋娜(Fei-Na Chen)、陳學德(Hsueh-Te Chen)、李正淳(Cheng-Chun Lee)、吳錫金(Wu,Hsi-Chin)*,Critical Thinking, Narrative Medicine and the Course Design of Medical Malpractice for Preclinical Students - The Experience from China Medical University,Journal of Medical Education,2014 Aug,18(3):102-113 | 2014 . 08 |
66 | 陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、陳至正(Chi-Cheng Chen)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、陳國樑(Chen, Kuo-Liang)、鄒頡龍(Chieh-Lung Chou)、陳汶吉(Chen, Wen-Chi)、張兆祥(Chang,Chao-Hsiang)*,Spontaneous ureteral rupture and review of the literature,AMERICAN JOURNAL OF EMERGENCY MEDICINE,2014 Jul,32(7):772-774 | 2014 . 07 |
67 | (Hsin-Ho Liu)*、(Yuh-Shyan Tsai)、(Chen-Li Lai)、湯智昕(Tang Chih-Hsin)、賴志河(Chih-Ho Lai)、吳錫金(Wu,Hsi-Chin)*、謝哲宗(Jer-Tsong Hsieh)*、楊啟瑞(Che-Rei Yang)*,Evolving Personalized Therapy for Castration-Resistant Prostate Cancer,BioMedicine,2014 Mar,4(1):7-15 | 2014 . 03 |
68 | 張玉君(Yu-Jun Chang)、張志宏(Chih-Hung Chang)、彭巧伶(Chiao-Ling Peng)、吳錫金(Wu,Hsi-Chin)、林雪淳(HSUEH-CHUN LIN)、王中儀(JONG-YI WANG)、李采娟(Tsai-Chung Li)、葉懿諄(Yi-Chun Yeh)、梁文敏(Wen-Miin Liang)*,Measurement equivalence and feasibility of the EORTC QLQ-PR25: paper-and-pencil versus touch-screen administration,Health and Quality of Life Outcomes,2014 Feb,12(23): | 2014 . 02 |
69 | 陳坤堡(Kuen-Bao Chen)、江易穎(Yi-Ying Chiang)*、黃淑芬(Shu-Fen Huang)、吳錫金(Wu,Hsi-Chin)、黃文良(Wen-Liang Huang)、藍忠亮(Joung-Liang Lan),團隊資源管理之醫學中心麻醉科經驗,醫療品質,2014 Jan,8(): | 2014 . 01 |
70 | (Tien-Huang Lin)、(Wen-Chi Chen)、吳錫金(Wu,Hsi-Chin)、(Wen-Shin Chien)、(Shang-Seu Lec)*、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、(Wei-Jen Ting)、(Sheng-Chu Kuo)*、黃志揚(Chih-Yang Huang)*,Induction of Apoptosis in Human DU145 Prostate Cancer Cells by KHC-4 Treatment,CHINESE JOURNAL OF PHYSIOLOGY,2014 ,57(2):1-6 | 2014 . |
71 | 張文馨(WEN-SHIN CHANG)、蔡佳紋(Chia-Wen Tsai)、紀宏學(HONG-XUE JI)、吳錫金、張怡婷(YI-TING CHANG)、連啟舜(Chi-Shun Lien)、廖文玲(WEN-LING LIAO)、沈戊忠、蔡長海(Chang-Hai Tsai)、包大靝(Da-Tian Bau)*,Associations of Cyclooxygenase 2 Polymorphic Genotypes with Bladder Cancer Risk in Taiwan,ANTICANCER RESEARCH,2013 Dec,33(12):5401-5406 | 2013 . 12 |
72 | 張文馨(Wen-Shin Chang)、林松水(Song-Shei Lin)、李芳菁(Fang-Jing Li)、蔡佳紋(Chia-Wen Tsai)、李龍緣(Long-Yuan Li)、連啟舜(Chi-Shun Lien)、廖文玲(Wen-Ling Liao)、吳錫金(Wu,Hsi-Chin)、蔡長海(Chang-Hai Tsai)、施子卿(TZU-CHING SHIH)*、包大靝(Da-Tian Bau)*,Significant Association of Caveolin-1 (CAV1) Genotypes with Upper Tract Urothelial Cancer,ANTICANCER RESEARCH,2013 Nov,33(11):4907-4912 | 2013 . 11 |
73 | 王昶弼(Chang-Bi Wang)、林建甫(Chien-Fu Jeff Lin)*、梁文敏(Wen-Miin Liang)*、鄭奇浲(Chi-Fung Cheng)、張玉君(Yu-Jun Chang)、吳錫金(Wu,Hsi-Chin)、吳聰能(Trong-Neng Wu)、呂才學(Tsai-Hsueh Leu),Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study,BONE,2013 Sep,56(1):147-153 | 2013 . 09 |
74 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、連啟舜(Chi-Shun Lien)、吳錫金(Wu,Hsi-Chin)、蕭博任(Po-Jen Hsiao)、鄒頡龍(Chieh-Lung Chou)*,Remote monitoring of videourodynamics using smart phone and free instant messaging software,NEUROUROLOGY AND URODYNAMICS,2013 Jul,(): | 2013 . 07 |
75 | 洪世昌(Shih-Chan Hung)、賴世偉(Shih-Wei Lai)、(Pang-Yao Tsai)、(Pei-Chun Chen)、吳錫金(Wu,Hsi-Chin)、(Wen-Hsu Lin)、宋鴻樟(Fung-Chang Sung)*,Synergistic Interaction of Benign Prostatic Hyperplasia and Prostatitis on Prostate Cancer Risk,BRITISH JOURNAL OF CANCER,2013 May,108(9):1778-1783 | 2013 . 05 |
76 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)、陳至正(Chi-Cheng Chen)、陳國樑(Chen, Kuo-Liang)、張士三(Chang, Shi-San)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、鄒頡龍(Chieh-Lung Chou)、吳錫金(Wu,Hsi-Chin)*,C index is associated with both short-term and long-term renal functional outcome after partial nephrectomy,Urological Science,2013 May,24(2):46-50 | 2013 . 05 |
77 | 連啟舜(Chi-Shun Lien)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Chen, Wen-Chi)*,Genital chlamydial infection in Taiwan,Urological Science,2013 Apr,24(1):7-9 | 2013 . 04 |
78 | (K Wu)、(J Liu)、(S-F Tseng)、(C Gore)、(Z Ning)、(N Sharifi)、(L Fazil)、(M Gleave)、(P Kapur)、(G Xiao)、(X Sun)、(OK Oz)、(W Min)、(G Alexandrakis)、楊啟瑞(Che-Rei Yang)、謝嘉玲(Chia-Ling Hsieh)、吳錫金(Wu,Hsi-Chin)、(D He)、(D Xie)、謝哲宗(Jer-Tsong Hsieh)*,The role of DAB2IP in androgen receptor activation during prostate cancer progression,ONCOGENE,2013 Apr,():1 | 2013 . 04 |
79 | 吳禮字(Wu Lii Tzu)、許儷絹(Li-Chuan Hsu)、孫盛生(Shung-Shung Sun)、吳錫金(Wu,Hsi-Chin)、涂明君(Ming-Gene Tu)、關超然(Chiu-Yin Kwan)*,The Change of Student Perception toward PBL in a Medical School with a hybrid-PBL Preclinical Curriculum in Taiwan,Journal of Medical Education,2013 Mar,16(3):97-113 | 2013 . 03 |
80 | 張文馨(Wen-Shin Chang)、蔡佳紋(Chia-Wen Tsai)、鄭光皓(Kuang-Hao Cheng)、連啟舜(Chi-Shun Lien)、黃志平(Chi-Ping Huang)、廖文玲(Wen-Ling Liao)、李孟軒(Meng-Hsuan Lee)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、林正介(Cheng-Chieh Lin)、包大靝(Da-Tian Bau)*,The Role of APEX1/Ref-1 (apurinic/apyrimidic endonuclease DNA-repair gene) in Renal Cell Carcinoma,Adaptive Medicine,2012 Dec,4(4):216-223 | 2012 . 12 |
81 | 陳冬生(Tung-Sheng Chen)、(Show-Yih Liou)、吳錫金(Wu,Hsi-Chin)、(Miao-Lin Wu)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、黃志揚(Chih-Yang Huang)*、(Yen-Lin Chang)*,The application of (-)-epigallocatechin gallate in preparation of an antioxidant dialysate,Food Chemistry,2012 Oct,134(3):1307-1311 | 2012 . 10 |
82 | 侯曼貞(Hour Mann-Jen)、蔡士彰(Shih-Chang Tsai)、吳錫金(Wu,Hsi-Chin)、林孟崴(MENG-WEI LIN)、鍾景光(Jing-Gung Chung)、吳金濱(Jin Bin Wu)、江若華(JO-HUA CHIANG)、(MINORU TSUZUKI)、楊家欣(Yang Jai-Sing)*,Antitumor effects of the novel quinazolinone MJ-33: Inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells,INTERNATIONAL JOURNAL OF ONCOLOGY,2012 Oct,41(4):1513-1519 | 2012 . 10 |
83 | 陳冬生(Tung-Sheng Chen)、(Show-Yih Liou)、吳錫金(Wu,Hsi-Chin)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、黃志揚(Chih-Yang Huang)*、(Yen-Lin Chang)*,Amino acids with basic amino side chain accelerate the pro-oxidant ability of polyphenolic compounds,Food Chemistry,2012 Sep,134(1):9-14 | 2012 . 09 |
84 | 張文馨(Wen-Shin Chang)、(Hung-Lung Ke)、蔡佳紋(Chia-Wen Tsai)、連啟舜(Chi-Shun Lien)、廖文玲(Wen-Ling Liao)、(Hui-Hui Lin)、李孟軒(Meng-Hsuan Lee)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、陳至正(Chi-Cheng Chen)、李鳳琴(Hong-Zin Lee)、包大靝(Da-Tian Bau)*,The role of XRCC6 functional polymorphism T-991C in renal cell carcinoma,ANTICANCER RESEARCH,2012 Sep,32(9):3855-3860 | 2012 . 09 |
85 | 張玉君(Chang, Yu-Jun)、梁文敏(Liang WM)、吳錫金(Wu,Hsi-Chin)、林雪淳(HSUEH-CHUN LIN)、王中儀(JONG-YI WANG)、李采娟(Tsai-Chung Li)、葉懿諄(Yi-Chun Yeh)、張志宏(Chih-Hung Chang)*,Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients,Health and Quality of Life Outcomes,2012 Aug,10(0):96-96 | 2012 . 08 |
86 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、黃志平(Chi-Ping Huang)、陳至正(Chen, Chi-Cheng)、陳國樑(Chen, Kuo-Liang)、張士三(Chang, Shi-San)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、鄒頡龍(Chieh-Lung Chou)、吳錫金(Wu,Hsi-Chin)*,The impact of gender and size on the pathology of small renal mass,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2012 Jul,28(7):369-372 | 2012 . 07 |
87 | 林雪淳(HSUEH-CHUN LIN)*、吳錫金(Wu,Hsi-Chin)、張志宏(Chih-Hung Chang)、李采娟(Tsai-Chung Li)、梁文敏(Liang WM)、王中儀(JONG-YI WANG),A Real Time Online Assessment System with Modelized Architecture on Clinical Infometrics for Patient Reported Outcomes of Prostate Cancer,Computer Methods and Programs in Biomedicine,2012 Jun,106(3):249-259 | 2012 . 06 |
88 | 陳國樑(Chen, Kuo-Liang)*、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang),Tissue-engineered constructs for urethral regeneration,Urological Science,2012 Jun,23(2):42-44 | 2012 . 06 |
89 | 蕭琬琦(Wan-Chi Hsiao)、宋賢穎(Shian-Ying Sung)、廖佳慧、吳錫金(Wu,Hsi-Chin)、謝嘉玲(Chia-Ling Hsieh)*,Vitamin D3-Inducible Mesenchymal Stem Cell-Based Delivery of Conditionally Replicating Adenoviruses Effectively Targets Renal Cell Carcinoma and Inhibits Tumor Growth,MOLECULAR PHARMACEUTICS,2012 May,9(5):1396-1408 | 2012 . 05 |
90 | 田霓(Tien Ni)、蕭瓊子(Chiung-Tzu Hsiao)、施木青(Mu-Chin Shih)、陳貽善(Yi-Shan Chen)、吳錫金(Wu,Hsi-Chin)、劉淳儀(CHUN YI LIU)、洪曉音(Hung, Shiao-Yin)*,臨床實驗室的風險管理,醫療品質,2011 Nov,5(6):74-78 | 2011 . 11 |
91 | 張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、(Hung-Lung Ke)、(Hui-Hui Lin)、沈戊忠(Wu-Chung Shen)、孫盛生(Shung-Shung Sun)、蔡佳紋(Chia-Wen Tsai)、(Ru-Yin Tsai)、包大靝(Da-Tian Bau)*,The Genetic Role of Cyclooxygenase 2 in Ureter Cancer in Taiwan,Adaptive Medicine,2011 Oct,3(2):99-105 | 2011 . 10 |
92 | 李建正(Chien-Cheng Lee)、李妙蓉(Miau-Rong Lee)、許儷絹(Li-Chuan Hsu)*、吳錫金(Wu,Hsi-Chin)、沈戊忠(Wu-Chung Shen)、林正介(Cheng-Chieh Lin),The influence of type of community organization on service-learning in medical students,Journal of Medical Education,2011 Sep,15(): | 2011 . 09 |
93 | 辛幸珍(Hsin-Chen Hsin)*、戴志展(Chih-Jaan Tai)、吳錫金(Wu,Hsi-Chin),Design of PBL cases in bioethical education spanning across general and professional education,Journal of Medical Education,2011 Sep,15(3):281-288 | 2011 . 09 |
94 | 吳錫金(Wu,Hsi-Chin)、楊卿堯(Ching-Yao Yang)、洪東榮(Hung, Dong-Zong)、(Chin-Chuan Su)、陳國樑(Chen, Kuo-Liang)、(Cheng-Chieh Yen)、何宗融(Tsung-Jung Ho)、蘇奕彰(Yi-chang, Su)、黃俊發(Chun-Fa Huang)、陳俊宏(Chun-Hung Chen)、(Ling-Mei Tsai)、陳雅雯(Ya-Wen Chen)*,Nickel(II) induced JNK activation-regulated mitochondria-dependent apoptotic pathway leading to cultured rat pancreatic ß-cell death,TOXICOLOGY,2011 Aug,289(2011):103-111 | 2011 . 08 |
95 | 呂恬慧(Tien-Hui Lu)、謝尚諭(Shan-Yu Hsieh)、巖正傑(Cheng-Chien Yen)、吳錫金(Wu,Hsi-Chin)、陳國樑(Chen, Kuo-Liang)、洪東榮(Hung, Dong-Zong)、陳俊宏(Chun-Hung Chen)、吳錦景(Chin-Ching Wu)、蘇奕彰(Yi-chang, Su)、陳雅雯(Ya-Wen Chen)、劉興華(Shing-Hwa Liu)*、黃俊發(Chun-Fa Huang)*,Involvement of oxidative stress-mediated ERK1/2 and p38 activation regulated mitochondria-dependent apoptotic signals in methylmercury-induced neuronal cell injury,TOXICOLOGY LETTERS,2011 Jul,204(1):71-80 | 2011 . 07 |
96 | 陳冬生(Tung-Sheng Chen)、(Show-Yih Liou)、吳錫金(Wu,Hsi-Chin)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、黃志揚(Chih-Yang Huang)*、(Yen-Lin Chang)*,Efficacy of Epigallocatechin-3-Gallate and Amla (Emblica officinalis) Extract for the Treatment of Diabetic-Uremic Patients,JOURNAL OF MEDICINAL FOOD,2011 Jul,14(7/8):718-723 | 2011 . 07 |
97 | 陳冬生(Tung-Sheng Chen)、(Show-Yih Liou)、吳錫金(Wu,Hsi-Chin)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、黃志揚(Chih-Yang Huang)*、(Yen-Lin Chang)*,Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia,INTERNATIONAL UROLOGY AND NEPHROLOGY,2011 Jun,43(2):471-474 | 2011 . 06 |
98 | 吳錦景(Chin-Ching Wu)、(Yeong S. Pu)、吳錫金(Wu,Hsi-Chin)、(Chun-Yuh Yang)、(Yi-Chun Chen)*,Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium,Chemosphere,2011 May,83(8):1188-1191 | 2011 . 05 |
99 | 黃志揚(Chih-Yang Huang)、(Hsin-Shan Yu)、賴東淵(Tung-Yuan Lai)、(Yu-Lan Yeh)、(Cheng-Chuan Su)、(His-Hsien Hsu)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、吳錫金(Wu,Hsi-Chin)、湯智昕(Tang Chih-Hsin)*,Leptin increases motility and integrin up-regulation in human prostate cancer cells,JOURNAL OF CELLULAR PHYSIOLOGY,2011 May,226(5):1274-1282 | 2011 . 05 |
100 | 張維君(Wei-Chun Chang)、蕭明文(Meen-Woon Hsiao)、吳錫金(Wu,Hsi-Chin)、張穎宜(Yin-Yi Chang)、洪耀欽(Yao-Ching Hung)、葉哲全(Je-Chiuan Ye)*,The analysis of eugenol from the essential oil of Eugenia caryophyllata by HPLC and against the proliferation of cervical cancer cells,Journal of Medicinal Plants Research,2011 Apr,5(7):1121-1127 | 2011 . 04 |
101 | 謝博帆(Po-Fan Hsieh)*、陳冠亨(Guang-Heng Chen)、(Sung-Ting Chen)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、鄒頡龍(Chieh-Lung Chou),Polypoid Cystitis Presenting as a Protruding Urethral Mass,台灣泌尿科醫學會雜誌,2011 Mar,22(1):46-48 | 2011 . 03 |
102 | 林雪淳(HSUEH-CHUN LIN)*、吳錫金(Wu,Hsi-Chin)、張志宏(Chih-Hung Chang)、李采娟(Tsai-Chung Li)、梁文敏(Liang WM)、王中儀(JONG-YI WANG),Development of a Real-Time Clinical Decision Support System upon the Web MVC-based Architecture for Prostate Cancer Treatment,BMC Medical Informatics and Decision Making,2011 Mar,(): | 2011 . 03 |
103 | 張兆祥(Chang,Chao-Hsiang)、彭賢祐(Hsien-Yu Peng)、吳錫金(Wu,Hsi-Chin)、(Cheng-Yuan Lai)、(Ming-Chun Hsieh)、林則彬(Tzer-Bin Lin)*,Cyclophosphamide induces NR2B phosphorylation-dependent facilitation on spinal reflex potentiation.,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2011 Mar,300.(3.):F692.-9. | 2011 . 03 |
104 | 吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、鄒永恩(Yung-An Tsou)、蔡佳紋(Chia-Wen Tsai)、林正介(Cheng-Chieh Lin)*、包大靝(Da-Tian Bau)*,Significant Association of Caveolin-1 (Cav-1) Genotypes with Prostate Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2011 Feb,31(2):745-749 | 2011 . 02 |
105 | 吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、彭賢祐(Hsien-Yu Peng)、(Gin-Den Chen)、(Cheng-Yuan Lai)、(Ming-Chun Hsieh)、林則彬(Tzer-Bin Lin)*,EphrinB2 induces pelvic-urethra reflex potentiation via Src kinase-dependent tyrosine phosphorylation of NR2B.,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2011 Feb,300(2):F403-F411 | 2011 . 02 |
106 | 彭賢祐(Hsien-Yu Peng)、張兆祥(Chang,Chao-Hsiang)、(Shin-Jei Tsai)、(Cheng-Yuan Lai)、(Kwong-Chung Tung)、吳錫金(Wu,Hsi-Chin)*、林則彬(Tzer-Bin Lin)*,Protein kinase A-dependent spinal α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate receptor trafficking mediates the capsaicin-induced colon-urethra cross-organ reflex sensitization.,ANESTHESIOLOGY,2011 Jan,114(1):70-83 | 2011 . 01 |
107 | 吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、(HUNG-LUNG KE)、張文馨(WEN-SHIN CHANG)、(HUI-NI CHENG)、(HUI-HUI LIN)、(CHI-YU WU)、蔡佳紋(CHIA-WEN TSAI)、(RU-YIN TSAI)、羅偉忠(Lo Woei Chung)、包大靝(Da-Tian Bau)*,Associations of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer in Taiwan,ANTICANCER RESEARCH,2011 Jan,31(1):221-226 | 2011 . 01 |
108 | 陳雅雯(Ya-Wen Chen)*、陳國樑(Chen, Kuo-Liang)、陳俊宏(Chun-Hung Chen)、吳錫金(Wu,Hsi-Chin)、(Chin-Chuan Su)、吳錦景(Chin-Ching Wu)、魏宗德(Tzong-Der Way)、洪東榮(Hung, Dong-Zong)、(Cheng-Chien Yen)、楊媛婷(Yuan-Ting Yang)、呂恬慧(Tien-Hui Lu),Pyrrolidine dithiocarbamate (PDTC)/Cu complex induces lung epithelial cell apoptosis through m itochondria and ER-stress pathways,TOXICOLOGY LETTERS,2010 Dec,199(3):333-340 | 2010 . 12 |
109 | (Kai-Ning Yang)、陳淑真(Shu-Chen Chen)、(Shu-Yueh Chen)*、(Chao-Hsiang Chang)、吳錫金(Wu,Hsi-Chin)、鄒頡龍(Chieh-Lung Chou),Female voiding postures and their effects on micturition.,INTERNATIONAL UROGYNECOLOGY JOURNAL,2010 Nov,21(11):1371-1376 | 2010 . 11 |
110 | 吳錫金(Wu,Hsi-Chin)、(Chiu CH)、(Tung KC)、(Chen GD)、彭賢祐(Hsien-Yu Peng)、林則彬(Tzer-Bin Lin)*,Dopaminergic D2 receptors activate PKA to inhibit spinal pelvic-urethra reflex in rats,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2010 Sep,299():F681-F686 | 2010 . 09 |
111 | 鄒頡龍(Chieh-Lung Chou)、張兆祥(Chang,Chao-Hsiang)、陳至正(Chen, Chi-Cheng)、吳錫金(Wu,Hsi-Chin)、吳博倫(Po-Lun Wu)、陳國樑(Chen, Kuo-Liang)*,Women Urinate in the Standing Position Do Not Increase Post-Void Residual Urine Volumes,NEUROUROLOGY AND URODYNAMICS,2010 Sep,29(7):1299-1300 | 2010 . 09 |
112 | 吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、蔡如愔(RU-YIN TSAI)、林志學(Chih-Hsueh Lin)、王柔分(ROU-FEN WANG)、蔡佳紋(CHIA-WEN TSAI)、陳坤堡(Kuen-Bao Chen)、姚俊旭(Chun-Hsu Yao)、邱昌芳(Chang-Fang Chiu)、包大靝(Da-Tian Bau)*、林正介(Cheng-Chieh Lin)*,Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan,ANTICANCER RESEARCH,2010 Sep,30(9):3573-3578 | 2010 . 09 |
113 | 陳冬生(Tung-Sheng Chen)、(SHOW-YIH LIOU)、吳錫金(Wu,Hsi-Chin)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、黃志揚(Chih-Yang Huang)*、(YEN-LIN CHANG)*,New Analytical Method for Investigating the Antioxidant Power of Food Extracts on the Basis of Their Electron-Donating Ability: Comparison to the Ferric Reducing/Antioxidant Power (FRAP) Assay,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2010 Aug,58(15):8477-8480 | 2010 . 08 |
114 | (Chang JL)、彭賢祐(Hsien-Yu Peng)、吳錫金(Wu,Hsi-Chin)、(Lu HT)、(Pan SF)、(Chen MJ)、林則彬(Tzer-Bin Lin)*,Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2010 Jul,299(1):F43-F48 | 2010 . 07 |
115 | 吳錫金(Wu,Hsi-Chin)、(Chun-Hsien Chiu)、(Kwong-Chung Tung)、(Gin-Den Chen)、彭賢祐(Hsien-Yu Peng)*、林則彬(Tzer-Bin Lin)*,Dopaminergic D2 receptors activate PKA to inhibit spinal pelvic-urethra reflex in rats.,AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY,2010 Jun,(): | 2010 . 06 |
116 | 溫岩芳(Yen-Fang Wen)、楊家欣(Yang Jai-Sing)、郭盛助(Sheng-Chu Kuo)、(Chrong-Shiong Hwang)、鍾景光(Jing-Gung Chung)、吳錫金(Wu,Hsi-Chin)、黃雯雯(Wenwen Huang)、詹家樺(Jia-Hua Jhan)、(Chung-Ming Lin)*、陳慧婕(Hui-Jye Chen)*,Investigation of anti-leukemia molecular mechanism of ITR-284, a carboxamide analog, in leukemia cells and its effects in WEHI-3 leukemia mice,BIOCHEMICAL PHARMACOLOGY,2010 Feb,79(3):389-398 | 2010 . 02 |
117 | 彭賢祐(Hsien-Yu Peng)、(Chen GD)、(Lai CY)、(Hsieh MC)、(Hsu HH)、吳錫金(Wu,Hsi-Chin)*、林則彬*,PI3K modulates estrogen-dependent facilitation of colon-to-urethra cross-organ reflex sensitization in ovariectomized female rats,JOURNAL OF NEUROCHEMISTRY,2010 Jan,113(1):54-66 | 2010 . 01 |
118 | 謝右文(Yow-Wen Hsieh)、林玟玲(Wen-Ling Lin)*、姚淑惠(Shu-Hui Yao)、賴振榕(Lai Zhen Rong)、吳錫金(Wu,Hsi-Chin),疑似注射indomethacin引起低血糖之案例報告,藥物安全簡訊,2009 Dec,Dec(28):6-18 | 2009 . 12 |
119 | 陳汶吉(Chen, Wen-Chi)、劉心萍(Hsin-Ping Liu)、吳錫金(Wu,Hsi-Chin)、(Chou-Huang Tsai)、陳慧毅(Huey-Yi Chen)、陳幸宜(Hsin-Yi Chen)、蔡輔仁(Fuu-Jen Tsai)、(Chiao-Hui Chang)、(Po-Len Liu)、(Feng-Yen Line)、(Yi-Chun Chang)、林維勇(Wei-Yong Lin)、陳永祥(Yung-Hsiang Chen)*,Preliminary study of ethylene glycol-induced alanine-glyoxylate aminotransferase 2 expression in rat kidney,Current urology reports,2009 Oct,(3):129-135 | 2009 . 10 |
120 | 張兆祥(Chang,Chao-Hsiang)、王柔分(ROU-FEN WANG)、蔡如愔(RU-YIN TSAI)、吳錫金(Wu,Hsi-Chin)、王仲興(Chung-Hsing Wang)、蔡佳紋(CHIA-WEN TSAI)、張佳霖(CHIA-LIN CHANG)、鄒永恩(Yung-An Tsou)、劉秋松(Chiu-Shong Liu)、包大靝(Da-Tian Bau)*,Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.,ANTICANCER RESEARCH,2009 Oct,29(10):3903-3907 | 2009 . 10 |
121 | 孫盛生(Shung-Shung Sun)、張兆祥(Chang,Chao-Hsiang)、丁慧枝(Hueisch-Jy Ding)、高嘉鴻(Chia-Hung Kao)、吳錫金(Wu,Hsi-Chin)、謝德鈞(Te-Chun Hsieh)*,Preliminary Study of Detecting Urothelial Malignancy with FDG PET in Taiwanese ESRD Patients,ANTICANCER RESEARCH,2009 Aug,29(8):3459-3464 | 2009 . 08 |
122 | 陳至正(Chen, Chi-Cheng)、張兆祥(Chang,Chao-Hsiang)*、吳錫金(Wu,Hsi-Chin)、葉進仲(Yeh, Chin-Chung)、鄒頡龍(Chieh-Lung Chou)、謝登富(Deng-Fu Hsieh)、陳汶吉(Chen, Wen-Chi)*,Detecting Upper Urinary Tract Malignancy in Patients with Staghorn stone: Results of a Routine Biopsy,Current urology reports,2009 Aug,3(2):61-67 | 2009 . 08 |
123 | 周立琛(Chou Li-Chen)、楊家欣(Yang Jai-Sing)、黃麗嬌(Li-Jiau Huang)、吳錫金(Wu,Hsi-Chin)、呂啟誠(Chi-Cheng Lu)、江若華(Jo-Hua Chiang)、陳冠廷(Kuan-Tin Chen)、郭盛助(Sheng-Chu Kuo)*、鍾景光(Jing-Gung Chung)*,The synthesized 2-(2-fluorophenyl)-6,7- methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells,JOURNAL OF GASTROENTEROLOGY,2009 Aug,44(10):1055-1063 | 2009 . 08 |
124 | 殷梅津(YIN, MEI-CHIN)、林俊哲(Chun-che Lin)、吳錫金(Wu,Hsi-Chin)、曹世明(Shih-ming Tsao)、許成光(Cheng-kung Hsu),Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix and prostate cancer cells: potential mechanisms of action,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2009 Jul,(57):6468-6473 | 2009 . 07 |
125 | 張兆祥(Chang,Chao-Hsiang)、張嘉琳(CHIA-LIN CHANG)、蔡佳紋(CHIA-WEN TSAI)、吳錫金(Wu,Hsi-Chin)、邱昌芳(Chang-Fang Chiu)、王柔分(ROU-FEN WANG)、劉秋松(Chiu-Shong Liu)、林正介(Cheng-Chieh Lin)、包大靝(Da-Tian Bau)*,Significant Association of an XRCC4 Single Nucleotide Polymorphism with Bladder Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2009 May,29(5):1777-1782 | 2009 . 05 |
126 | 張兆祥(Chang,Chao-Hsiang)、邱昌芳(Chang-Fang Chiu)、(Shiu-Yun Liang)、吳錫金(Wu,Hsi-Chin)、張嘉琳(Chia-Lin Chang)、蔡佳紋(Chia-Wen Tsai)、王惠暢(Hwei-Chung Wang)、李鳳琴(Hong-Zin Lee)*、包大靝(Da-Tian Bau)*,Significant Association of Ku80 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan,ANTICANCER RESEARCH,2009 May,29(1):1275-1280 | 2009 . 05 |
127 | 林玟玲(Wen-Ling Lin)、黃靖雅(Ching-Ya Huang)、吳錫金(Wu,Hsi-Chin)、謝右文(Yow-Wen Hsieh)*,藥物不良反應通報分析-Warfarin,藥物安全簡訊,2008 Dec,24(1):11-18 | 2008 . 12 |
128 | 林嘉德(Chia-Der Lin)、吳錫金(Wu,Hsi-Chin)、沈戊忠(Wu-Chung Shen)、廖世傑(Shih-Chieh Liao)、蔡崇豪(Chon-Haw Tsai)*、林正介(Cheng-Chieh Lin),An Online PHS System to Promote Mutual Feedback in Clinical Medical Education,Journal of Medical Education,2008 Dec,12(4):197-207 | 2008 . 12 |
129 | 張兆祥(Chang,Chao-Hsiang)、邱昌芳(Chang-Fang Chiu)、吳錫金(Wu,Hsi-Chin)、曾憲彰(Hsien-Chang Tseng)、王仲興(Chung-Hsing Wang)、林正介(Cheng-Chieh Lin)、蔡佳紋(Chia-Wen Tsai)、梁雲(Shiu-Yun Liang)、王政力(Cheng-Li Wang)、包大靝(Da-Tian Bau)*,Significant association of XRCC4 single nucleotide polymorphisms with prostate cancer susceptibility in Taiwan.,MOLECULAR MEDICINE REPORTS,2008 Oct,1(1):525-530 | 2008 . 10 |
130 | 楊凱甯、陳淑月(Shu-Yueh, Chen)*、陳淑真、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、陳怡靜、鄒頡龍(Chieh-Lung Chou),Sitting and Crouching Over the Public Toilet Seat and Its Effect on Maturation.,INTERNATIONAL UROGYNECOLOGY JOURNAL,2008 Sep,19(Supp1):S77-S78 | 2008 . 09 |
131 | 陳國樑(Kuo-Liang Chen)、蘇百弘(Bai-Horng Su)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、張士三(CHANG S.S.)*,Surveillance of Male Genital Anomalies in Newborns: Experience in a Medical Center in Central Taiwan,Mid-Taiwan Journal of Medicine,2008 Jun,13(2):95-99 | 2008 . 06 |
132 | 吳錫金(Wu,Hsi-Chin)、(Yeh, Yu-Lan)、郭薇雯(Wei-Wen Kuo)、(Huang, Shu-kuei)、(Kuo, Wu-Hsien)、(Hsieh, Dennis Jine-yuan)、(Wu, Ching-lin)、蔡長海(Chang-Hai Tsai)、李信達(Shin-Da Lee)*、黃志揚(Chih-Yang Huang)*,P38 mitogen-activated protein kinase pathways are involved in the hypertrophy and apoptosis of cardiomyocytes induced by Porphyromonas gingivalis conditioned medium,CELL BIOCHEMISTRY AND FUNCTION,2008 Mar,26(2):246-255 | 2008 . 03 |
133 | (Yung-Cheng Chiu)、(Rong-Sen Yang)、(Kuo-Hsien Hsieh)、馮逸卿(Yi-Chin Fong)、魏宗德(Tzong-Der Way)、(Lee TS)、吳錫金(Hsi-Chin Wu)、(Wen-Mei Fu)*、湯智昕(Tang Chih-Hsin)*,Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes.,MOLECULAR PHARMACOLOGY,2007 Sep,72(3):695-703 | 2007 . 09 |
134 | 包大靝(Da-Tian Bau)、吳錫金(Wu,Hsi-Chin)、邱昌芳(Chang-Fang Chiu)、林正介(Cheng-Chieh Lin)、許欽木(Chin-Moo Hsu)、王政力(Wang, C. L)、王柔分(Wang, R. F)、蔡輔仁(Fuu-Jen Tsai)*,Association of XPD polymorphisms with prostate cancer in Taiwanese patients,ANTICANCER RESEARCH,2007 Jul,4C(27):2893-2896 | 2007 . 07 |
135 | 廖世傑(Shih-Chieh Liao)、吳錫金(Wu,Hsi-Chin)、黃崑巖、陳偉德(Walter Chen),Improving the Effect of Lecturing in Medical Education via the Classroom Response System,Journal of Medical Education,2007 Jun,11(2):74-79 | 2007 . 06 |
136 | 廖世傑(Shih-Chieh Liao)、黃崑巖、洪英聖*、陳偉德(Wei-De Chen)、洪武雄、吳錫金(Wu,Hsi-Chin),以專題式學習法建構醫學生對台灣原住民史之認知,通識教育學報,2007 Jun,(11):69-88 | 2007 . 06 |
137 | 劉緯陽(Wayne Young Liu)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chang,Chao-Hsiang)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、陳汶吉(Chen Wen-Chi)*,The Role of Retrograde Pyelography for Evaluation of Hematuria in Patients with Normal and Impaired Renal Function,Mid-Taiwan Journal of Medicine,2007 Mar,12(1):14-19 | 2007 . 03 |
138 | 葉進仲(Jin-Jung Ye)、林殿璜(Tien Huang Lin)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chao-Hsiang Chang)、陳家臻(Chia-Chen Chen)、陳汶吉(Chen Wen-Chi),A High Association of Upper Urinary Tract Transitional Cell Carcinoma with Non-Functioning Kidney Caused by Stone Disease in Taiwan.,UROLOGIA INTERNATIONALIS,2007 ,(79):19-23 | 2007 . |
139 | 姚淑惠(Shu-Hui Yao)、陳惠琍(Hui-Lee Chen)、賴琬姿(Wan-Tzu Lai)、吳錫金(Wu,Hsi-Chin)、林正介(Cheng-Chieh Lin)、蔡輝彥(Huei-Yann Tsai)*,Adverse drug reaction resporting system in a university hospital,Formosa Journal of Clinical Pharmacy,2006 Sep,1(14):29-42 | 2006 . 09 |
140 | 許儷絹(Li-Chuan Hsu)、吳錫金(Wu,His-Chin)、廖世傑(Shih-Chieh Liao),病人關懷與實踐課程的效果評價,中國循證醫學雜誌,2006 Sep,6(9):646-651 | 2006 . 09 |
141 | 吳錫金(Wu,Hsi-Chin)、張兆祥(Chao-Hsiang Chang)、萬磊(Lei Wan)、吳肇毅(Chao-I Wu)、蔡輔仁(Fuu-Jen Tsai)、陳汶吉(Chen Wen-Chi)*,IL-2 gene C/T polymorphism is associated with prostate cancer.,JOURNAL OF CLINICAL LABORATORY ANALYSIS,2006 Aug,(20):245-249 | 2006 . 08 |
142 | (YC lin)、(YC lin)、(TIS Hwang)、(HS Chiang)、(CR Yang)、吳錫金(Hsi-Chin Wu),Correlations of androgen deficiency with clinical symptoms in Taiwanese males,INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH,2006 Feb,(18):343-347 | 2006 . 02 |
143 | 陳偉德(Chen,Walter)、沈戊忠(Shen,Wu-Chung)、洪瑞松(Hung,Jui-Sung)、楊美都、陳安琪、彭成元(Peng,Cheng-Yuan)、林國瑞(Lin,Kuo-Juei)、林綽娟(Lin,Chouh-Jiuan)、蘇百弘、吳錫金(Wu,His-Chin)、許朝添(Chao-Tien Hsu)、黃水坤、林正介(Cheng-Chieh Lin)、蔡長海(Chang-Hai Tsai),新整合課程:分年、分段、分組教改之經驗及學生評論回饋分析,醫學教育,2005 Dec,9(4):320-332 | 2005 . 12 |
144 | 林殿璜、張兆祥(Chao-Hsiang Chang)、葉進仲(Chin-Chung Yeh)、陳武男、張士三(Shi-San Chang)、呂學甫(Hsuen-Fu Lu)、陳昶仲(Chang-Chung Chen)、楊慶鏘(Ching-Chiang Yang)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Wen-Chi Chen)*,Efficacy of extracorporeal shock wave lithotripsy on the treatment of upper urinary tract stones,Mid-Taiwan Journal of Medicine,2005 Jun,10(1):38-42 | 2005 . 06 |
145 | 陳階曉(CHIEH-HSIAO CHEN)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Chen Wen-Chi)、葉進仲(Jin-Jung Ye)、陳昶仲(chang-chung Chen)、張兆祥(Chao-Hsiang Chang)*,Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma- China Medical Universi ty Hospital experience.,UROLOGY,2005 Apr,65(18):687-691 | 2005 . 04 |
146 | 謝登富(DENG-FU HSIEH)、張兆祥(Chang,Chao-Hsian)、陳汶吉(Chen,Wen-Chi)、鄒頡龍、吳錫金(Wu,His-Chin),Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.,Chinese Medical Journal (Taipei),2005 Apr,68(4):167-171 | 2005 . 04 |
147 | 吳錫金(Hsi-Chin Wu)、張兆祥(Chao-Hsiang Chang)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai)、蔡進發(Tsai JJP)、陳汶吉(Chen Wen-Chi)*,P53 gene Codon 72 Polymorphism But Not Tumor Necrosis Factor- Gene Is Associated with Prostate Cancer.,UROLOGIA INTERNATIONALIS,2004 Feb,73(2):41-46 | 2004 . 02 |
148 | 吳錫金(Hsi-Chin Wu)、張兆祥(Chao-Hsiang Chang)、陳汶吉(Chen Wen-Chi)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai),Urokinase Gene 3’-UTR T/C Polymorphism Is Not Associated With Bladder Cancer.,GENETICS AND MOLECULAR BIOLOGY,2004 ,27(1):15-16 | 2004 . |
149 | 葉進仲、陳階曉(CHIEH-HSIAO CHEN)、(林嘉禾)、張兆祥(Chang,Chao-Hsian)、吳錫金(Wu,His-Chin),A new technique for treating forgotten indwelling ureteral stents: silk loop assisted ureterorenoscopic lithotripsy,JOURNAL OF UROLOGY,2004 ,171():719-721 | 2004 . |
150 | 楊國政(Kuo-Cheng Yang)、吳錫金(Wu,Hsi-Chin)、張兆祥(Chao-Hsiang Chang)、陳國樑(Kuo-Liang Chen)*,The clinical significance of asymtomatic microscopic hematuria.,Mid-Taiwan Journal of Medicine,2003 Dec,8(Suppl 2):S108-S113 | 2003 . 12 |
151 | 陳昶仲(Chang-Chung Chen)、吳錫金(Hsi-Chin Wu)、張兆祥(Chao-Hsiang Chang)、陳汶吉(Wen-Chi Chen)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Eric Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、楊慶鏘(Ching-Chiang Yang)、張士三(CHANG S.S.)*,Comparison of ten TRUS-guided and six sextant prostate biopsy in the prostate cancer detection,Mid-Taiwan Journal of Medicine,2003 Dec,8(Suppl 2):S102-S107 | 2003 . 12 |
152 | (陳昶仲)、吳錫金(Wu,His-Chin)、張兆祥(Chang,Chao-Hsian)、葉進仲、鄒頡龍、(陳國梁)、楊慶鏘、張士三,十或十二針經直腸超音波攝護腺切片與傳統六針切片對攝護腺癌偵測的比較,中台灣醫學科學雜誌,2003 Nov,8(8):164-167 | 2003 . 11 |
153 | 林正介(Cheng-Chieh Lin)、吳錫金(Wu,Hsi-Chin)、陳汶吉(Chen Wen-Chi)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai),CYP17 gene promoter allelic variant is not associated with prostate cancer,UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS,2003 Jul,21(4):262-265 | 2003 . 07 |
154 | 陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu),Hyperoxaluria induced renal tubule injury and urolithiasis.,Formosan Journal of Medical Humanities ( 臺灣醫學人文學刊),2003 ,11(6):702-706 | 2003 . |
155 | 張維君(Chang,Wei-Chun)、李建忠、吳錫金(Wu,His-Chin)、葉聯舜(Yen,Lian-Shung),Laparoscopy-assisted vaginal hysterectomy clinical pathway: a multivariate analysis of impact on costs and quality of care.,GYNECOLOGIC AND OBSTETRIC INVESTIGATION,2003 ,55(00):231-234 | 2003 . |
156 | 吳錫金(Wu,Hsi-Chin)、(Chao-Hsiang Chang)、賴明美(Ming-May Lai)、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee)、高嘉鴻(Chia-Hung Kao),Using Tc-99m DMSA renal crtex scan to detect renal damage in women with type 2 diabetes,JOURNAL OF DIABETES AND ITS COMPLICATIONS,2003 ,17(5):297-300 | 2003 . |
157 | 張兆祥(Chao-Hsiang Chang)、吳錫金(Wu,Hsi-Chin)、蔡進發(Jeffery J.P. Tsai)、沈業有(Yeh-You Shen)、張賴昇平(Sheng-Pin Changlai)、高嘉鴻(Chia-Hung Kao)*,Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer,UROLOGIA INTERNATIONALIS,2003 ,3(70):311-315 | 2003 . |
158 | 吳錫金(Wu,Hsi-Chin)、(Wen-Shen Huang)、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee)、高嘉鴻(Chia-Hung Kao),Objective Evidence of a High Prevalence of Renal Damage in Women with Type 2 Diabetes by Technitium-99m DMSA Renal Cortex Scan Findings,ACTA NEUROLOGICA SCANDINAVICA,2003 ,61(1):50-54 | 2003 . |
159 | 林正介(Cheng-Chieh Lin)、吳錫金(Wu,Hsi-Chin)、蔡輔仁(Fuu-Jen Tsai)、陳慧毅(Huey-Yi Chen)、(Wei-Chi Chen),Vasuclar Endothelial growth Factor Gene-460 C/T Polymorpphism is a Biomarker for Prostate Cancer.,UROLOGY,2003 ,62(00):374-377 | 2003 . |
160 | 張兆祥(Chang,Chao-Hsian)、吳錫金(Wu,His-Chin)、蔡進發(J.-J.P. Tsai)、林正介(Lin,Cheng-Chieh)、李正淳(Lee,Chun-Cheng)、高嘉鴻(Kao,Chia-Hung)*,Usefulness of technetium-99m hexamethylpropylene amine oxime lung scan to detect subclinical lung injury in patients with chronic renal failure,LUNG,2003 ,181(2):97-101 | 2003 . |
161 | 陳汶吉(Chen Wen-Chi)、吳錫金(Wu,Hsi-Chin)、吳梅珍、許正德、蔡輔仁(Fuu-Jen Tsai)*,Vascular endothelial growth factor gene polymorphism is associated with calsium oxalate stone disease,UROLOGICAL RESEARCH,2003 ,31(00):218-222 | 2003 . |
162 | 蔡輔仁(Fuu-Jen Tsai)、吳錫金(Hsi-Chin Wu)、陳慧毅(Huey-Yi Chen)、呂學甫(Lu HF)、許正德(Hsu CD)、陳汶吉(Chen Wen-Chi)*,Association of E-Cadherin Gene 3'-UTR C/T Polymorphism with Calcium Oxalate Stone Disease,UROLOGIA INTERNATIONALIS,2003 ,(70):278-281 | 2003 . |
163 | 張兆祥(Chao-Hsiang Chang)、吳錫金(Wu,Hsi-Chin)、(Ruoh-Fang Yeh)、高嘉鴻(Chia-Hung Kao)*、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Tissue Polypeptide Specific Antigen (TPS) as a Tumor Marker in Renal Cell Carcinoma,ANTICANCER RESEARCH,2002 Sep,22(5):2949-2950 | 2002 . 09 |
164 | 吳錫金(Hsi-Chin Wu)、蔡輔仁(Fuu-Jen Tsai)、陳慧毅(Huey-Yi Chen)、呂學甫(Lu HF)、許正德(Hsu CD)、陳汶吉(Chen Wen-Chi),Relationship Between the P16 Gene Exon 3 C/G Polymorphism and Hydropyruvate Reductase (GRHPR) Gene Exon 6 G/A Polymorphism in Patients with Calcium Oxalate Stone: No Association,中台灣醫學科學雜誌,2002 ,7(2):94-100 | 2002 . |
165 | 陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu)、許正德(Hsu CD)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai),p21 Gene codon 31 polymorphism is associated with bladder cancer,UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS,2002 ,(7):63-66 | 2002 . |
166 | 吳錫金(Wu,Hsi-Chin)、孫盛生(Shung-Shung Sun)、高嘉鴻(Chia-Hung Kao)*、(Feng-Ju Chuang)、林正介(Cheng-Chieh Lin)、李正淳(Cheng-Chun Lee),Comparison of Radionuclide Imaging and Ultrasonography in the Differentiation of Acute Testicular Torsion and Inflammatory Testicular Disease,CLINICAL NUCLEAR MEDICINE,2002 ,27(7):490-493 | 2002 . |
167 | 陳汶吉(Chen Wen-Chi)、吳錫金(Wu,Hsi-Chin)、呂學甫(Lu HF)、陳慧毅(Huey-Yi Chen)、蔡輔仁(Fuu-Jen Tsai),Calcitonin Receptor Gene Polymorphism: A Possible Genetic Marker for Patients with Calcium Oxalate Stones in Taiwan,EUROPEAN UROLOGY,2001 ,39(39):716-719 | 2001 . |
168 | 陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu)、林武周(Wu-Chou Lin)、吳玫珍(Wu MC)、許正德(Hsu CD)、蔡輔仁(Fuu-Jen Tsai),The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men,BJU INTERNATIONAL,2001 ,88(4):432-436 | 2001 . |
169 | 陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu)、陳慧毅(Huey-Yi Chen)、吳玫珍(Wu MC)、許正德(Hsu CD)、蔡輔仁(Fuu-Jen Tsai),Interleukin – I Beta Gene and Receptor Antagonist Gene Polymorphisms in Patients with Calcium Oxalate Stone,UROLOGICAL RESEARCH,2001 ,(29):321-324 | 2001 . |
170 | 盧建興(Lu CH)、陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu)、呂學甫(Lu HF),Transrectal ultrasonography findings in patients with hemosspermia,Chinese Medical Journal (Taipei),2000 ,(63):558-562 | 2000 . |
171 | 陳汶吉(Chen Wen-Chi)、蔡輔仁(Fuu-Jen Tsai)、鄔哲源、吳錫金(Hsi-Chin Wu)、呂學甫(Lu HF)、李家維(Li CW),Distribution of p53 Codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumor,NEUROLOGICAL RESEARCH,2000 ,(28):293-296 | 2000 . |
172 | 陳汶吉(Chen Wen-Chi)、蔡輔仁(Fuu-Jen Tsai)、鄔哲源、吳錫金(Hsi-Chin Wu)、李家雄(Li CW),Does Ser364Pro Mutation of Connexin43 Exist in Taiwanese Patients with Ivemark Syndrome?,Chinese Medical Journal (Taipei),2000 ,(63):691-695 | 2000 . |
173 | 陳汶吉(Chen Wen-Chi)、蔡輔仁(Fuu-Jen Tsai)、鄔哲源、施怡如(Shi YR)、吳錫金(Hsi-Chin Wu),Mutation Analysis of Human LEFTY A and LEFTY B Genes in Children with Ivemark Syndrome,Acta Paediatrica Taiwanica,2000 ,(41):259-262 | 2000 . |
174 | 陳昶仲(Chen CC)、陳汶吉(Chen Wen-Chi)、呂學甫(Lu HF)、吳錫金(Hsi-Chin Wu),Urological problems in tethered cord syndrome,台灣泌尿科醫學會雜誌,2000 ,(11):6-11 | 2000 . |
175 | 盧建興(Lu CH)、呂學甫(Lu HF)、陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu),Infrared spectroscopic analysis of urinary tractstones,Mid-Taiwan Journal of Medicine,2000 ,(5):73-78 | 2000 . |
176 | 吳瑞芳(Wu RF)、陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu)、葉進仲(Jin-Jung Ye)、呂學甫(Lu HF)、張士三(CHANG S.S.)、楊慶鏘、鄒頡龍(Chieh-Lung Chou),Subcapsular hematoma of the kidney after extracorporeal shock-wave lithotrripsy,台灣泌尿科醫學會雜誌,1999 ,(10):164-167 | 1999 . |
177 | 陳汶吉(Chen Wen-Chi)、吳錫金(Hsi-Chin Wu),The Clinical Application of Clean Intermittent Self-catheterization,中台灣醫學科學雜誌,1998 ,(3):218-222 | 1998 . |
178 | 陳汶吉(Chen Wen-Chi)、盧建興(Lu CH)、呂學甫(Lu HF)、張士三(CHANG S.S.)、吳錫金(Hsi-Chin Wu),Management of Urinary Fistuia,中台灣醫學科學雜誌,1997 ,(2):16-22 | 1997 . |
179 | 呂學甫(Lu HF)、陳汶吉(Chen Wen-Chi)、盧建興(Lu CH)、吳錫金(Hsi-Chin Wu),Probelms encountered in the removal of a forgotten, emcrusted double-J catheter,台灣泌尿科醫學會雜誌,1996 ,(7):193-199 | 1996 . |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | Real World Experience of Enfortumab vedotin in Advanced Urothelial Carcinoma: Preliminary results in a Single Center,2024 台灣泌尿科醫學會年會,林口長庚醫院長庚國際會議中心,2024.08.16~2024.08.18, | 2024 . 08 |
2 | Radium-223 after docetaxel has similar efficacy and safety profile compared to docetaxel naive in mCRPC patient,2023日本泌尿科醫學會年會,Kobe Conventional Center,2023.04.20~2023.04.23, | 2023 . 04 |
3 | The role of SPARE nephrometry and tumor contact surface area in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,第110屆日本泌尿外科醫協會年會 (JUA),日本神戶,2023.04.20~2023.04.23, | 2023 . 04 |
4 | The Prevalence of Port-site Incisional Hernia After Urologic Robot-assisted Laparoscopic Surgery: A Single-Center Retrospective Study,台灣泌尿科醫學會年會,高雄萬豪酒店,2022.08.20~2022.08.21, | 2022 . 08 |
5 | Radium-223 for mCRPC: Real-world experience of a single-center,2021 台灣泌尿科醫學會年會,台中榮總,2021.12.25~2021.12.26, | 2021 . 12 |
6 | Neoadjuvant chemotherapy and adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma,台灣泌尿科醫學會年會,台大,2020.08.21~2020.08.23, | 2020 . 08 |
7 | The role of tumor contact surface area and SPARE nephrometry in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,2022 International Session of TUA Conference,高雄醫學大學,2020.08.20~2020.08.20, | 2020 . 08 |
8 | Outcome of lymph node dissection in renal pelvis urothelial carcinoma,台灣泌尿科醫學會年會,中國附醫,2019.08.16~2019.08.18, | 2019 . 08 |
9 | Real world experience of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer,2019 泌尿科醫學會年會,中國醫藥大學附設醫院,2019.08.16~2019.08.18, | 2019 . 08 |
10 | Adjuvant chemotherapy in T3/T4 upper urinary tract urothelial carcinoma—CMUH experience,台灣泌尿科醫學會年會國際場 ISTUA,中國附醫,2019.08.16~2019.08.18, | 2019 . 08 |
11 | The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, | 2019 . 03 |
12 | Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, | 2019 . 03 |
13 | Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, | 2019 . 03 |
14 | 針對高風險族群攝護腺癌使用根除性攝護腺併骨盆腔淋巴廓清手術治療:治療經驗,台灣泌尿科學會2018年會,台北榮民總醫院,2018.08.18~2018.08.19, | 2018 . 08 |
15 | Multiparametric Magnetic Resonance Imaging increases predictive accuracy of oncological outcomes after robot-assisted radical prostatectomy,台灣泌尿科醫學會年會,台北榮總,2018.08.18~2018.08.19, | 2018 . 08 |
16 | The Contribution of MMP-7 Genotypes to Renal Cell Carcinoma in Central Taiwan,33屆生物醫學聯合學術年會,國防醫學院,2018.03.24~2018.03.25, | 2018 . 03 |
17 | Oncological results in high risk group prostate patients between combined radiotherapy with hormone therapy: real world experience from Taiwan population,台灣泌尿科醫學會(TUA)107年度半年會,彰化基督教醫院,2018.01.20~2018.01.20, | 2018 . 01 |
18 | predictive markers for the prognosis of muscle invasive bladder cancer treated with neoadjuvant chemotherapy,泌尿科醫學會年會,高雄長庚,2017.08.19~2017.08.20, | 2017 . 08 |
19 | Longitudinal Assessment of using Common Benzodizaepine/non-benzodiazepine hypnotics among the Elderly,ISPOR 22ND ANNUAL INTERNATIONAL MEETING,Boston, MA, USA,2017.05.20~2017.05.24, | 2017 . 05 |
20 | Comparison the prediective value of nephrometry systems in postoperative split renal function determined by renal scintigraphy: CSA, C-index, P.A.D.U.A., and R.E.N.A.L.,The 105th annual meeting of the Japanese Urological Association,Hotel Shiroyama, Kagoshima Prefectural Citizens Exchange Center, Houzan Hall,2017.04.21~2017.04.24, | 2017 . 04 |
21 | CT histogram analysis in predicting size reduction of renal angiomyolipoma after transarterial embolization,The 105th Annual Meeting of the Japanese Urological Association,Hotel Shiroyama, Kagoshima Prefectural Citizens Exchange Center, Houzan Hall,2017.04.21~2017.04.24, | 2017 . 04 |
22 | Experience of partial cystectomy in bladder urothelial cancer,WCE 2016,The Cape Town International Convention Centre, Cape Town, South Africa,2016.11.08~2016.11.12,Oncology: Miscellaneous-Surgical outcomes | 2016 . 11 |
23 | ,膀胱泌尿上皮癌學術研討會,中國附醫癌症中心一樓階梯會議室,2016.10.22~2016.10.22,Best practice in and enhanced recovery after Robotic assisted radical cystectomy-Recommendation and Consensus review | 2016 . 10 |
24 | Significant Association of Cyclooxygenases 2 Genotypes with Upper Tract Urothelial Cancer,第31屆生物醫學聯合學術研討會,國防醫學院,2016.03.26~2016.03.27, | 2016 . 03 |
25 | The concordance between pre-operative MRI and pathology stage in patients with prostate cancer underwent prostatectomy in CMUH,103rd Annual Meeting of the Japanese Urological Association,Kanazawa,2015.04.18~2015.04.21,Prostate cancer diagnosis | 2015 . 04 |
26 | Significant Association of Caveolin-1 Genotypes with Renal Cell Carcinoma Risk in Taiwan,第30屆生物醫學聯合學術研討會,國防醫學院,2015.03.21~2015.03.22, | 2015 . 03 |
27 | The Role of Functional Polymorphisms of Cyclooxygenase 2 in Renal Cell Carcinoma,第30屆生物醫學聯合學術研討會,國防醫學院,2015.03.21~2015.03.22, | 2015 . 03 |
28 | Epidemiology of testicular tumors in Taiwan and subtype review – data from a medical center and Taiwan health insurance database,16th annual congress of Asia Pacific Association of Pediatric Urologists (APAPU 2014) 亞太小兒泌尿醫學會議,Nikko Japan , 日本日光,2014.11.20~2014.11.22, | 2014 . 11 |
29 | PRESERVATION OF THE ACCESSORY PUDENDAL ARTERIES DURING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY,World Congress of Endourology 2014,台北國際會議中心,2014.09.03~2014.09.07, | 2014 . 09 |
30 | SALVAGE CRYOABLATION FOR LOCAL RECURRENCE OF PROSTATE CANCER AFTER RADIATION THERAPY AND HORMONAL THERAPY,ISTUA 2014,台北國際會議中心,2014.09.06~2014.09.06, | 2014 . 09 |
31 | ,32nd World Congress of Endourology & SWL,Taipei International Convention Center (TICC) NO.1, Hsin-Yi Road, Sec 5, Taipei, Taiwan,2014.09.03~2014.09.07, | 2014 . 09 |
32 | PRIMARY ADRENAL INSUFFICIENCY WITH BILATERAL ADRENAL TUMOR: A CASE REPORT,台灣泌尿科醫學會年會,台北國際會議中心,2014.09.06~2014.09.07, | 2014 . 09 |
33 | Novel Association of Caveolin-1 (CAV1) Genotypes with Upper Tract Urothelial Cancer Risk,第29屆生物醫學聯合學術研討會,國防醫學院,2014.03.15~2014.03.16, | 2014 . 03 |
34 | 使用智慧型手機以及免費通訊軟體即時監控影像尿路動力學-運用於住院醫師教學,102年度標竿學習研討會 第三屆教學優良既教學創新成果經驗分享,中國醫藥大學安康大樓五樓教學部會議室(一),2013.11.09~2013.11.09,教學創新經驗分享 | 2013 . 11 |
35 | ,PPCS 2013 The 8th Pan-Pacific Contienece society meeting,韓國釜山,2013.09.26~2013.09.27,CPAP Therapy Improves Stage 1 Sleep Nocturia in Patient with Obstructive Sleep Apnea | 2013 . 09 |
36 | Preliminary Experience with da Vinci-assisted Laparoscopic Radical Prostatectomy in China Medical University Hospital,台灣泌尿科醫學會102年年會,義守大學教樓 義守大學教樓 A棟 1樓,2013.08.31~2013.08.31, | 2013 . 08 |
37 | ,第18屆第2次會員大會暨第35次學術研討會,義守大學燕巢校區,2013.08.31~2013.09.01,Remote Monitoring of VideourodynamicsUsing Smart Phone and Free Instant Messaging Software | 2013 . 08 |
38 | Use MRI to localize prostate cancer before re-biopsy in patients with persistent high PSA and previous negative biopsy,The 4th Asian Congress of Abdominal Radiology,International Academic Research Building,2013.03.22~2013.03.24, | 2013 . 03 |
39 | QUALITY IMPROVEMENT OF INTEGRATED MEDICAL CARE TOWARD LOYAL PATIENTS IN A 2000-BED MEDICAL CENTER IN TAIWAN,ISPOR 5th ASIA-PACIFIC CONFERENCE,Taipei, Taiwan,2012.09.02~2012.09.04, | 2012 . 09 |
40 | THE INITIAL MANIFESTATION OF RENAL CELL CARCINOMA IS PULMONARY EMBOLISM: A CASE REPORT,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.08.17~2012.08.18, | 2012 . 08 |
41 | MANAGEMENT OF ENCASEMED AORTA AND INFERIOR VENA CAVA TO THE RETROPERITONEAL TUMOR: A CASE REPORT,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.08.17~2012.08.18, | 2012 . 08 |
42 | ,101年度台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.08.18~2012.08.19, | 2012 . 08 |
43 | 手術前尿路動力學顯示膀胱無收縮或低收縮不會影響婦女尿失禁手術結果,101台灣泌尿科醫學會第34次學術演講會,台大醫學院301會議室,2012.08.19~2012.08.19,婦女泌尿及尿路動態 | 2012 . 08 |
44 | OUTCOMES OF INTEGRATED MEDICAL CARE SERVICE PROVIDED IN OUTPATIENT UNITS IN A MEDICAL CENTER: TWO-YEAR EXPERIENCE,ISPOR 17th Annual International Meeting,Washington, DC, USA,2012.06.02~2012.06.06, | 2012 . 06 |
45 | 攝護腺癌臨床決策支援系統之使用對醫療照護品質之影響,2012年兩岸健康產業管理創新與展望學術研討會及玉山醫務暨健康管理學會學術研討會,台中市中國醫藥大學,2012.05.26~2012.05.26, | 2012 . 05 |
46 | Pharmaceutically-controlled replication of adenoviruses in mesenchymal stem cell-based cell carriers improves oncolytic virotherapy for advanced human renal cell carcinoma,2012 AACR Annual Meeting,Chicago, IL USA,2012.03.31~2012.04.04, | 2012 . 03 |
47 | PLATELET DERIVED GROWTH FACTOR (PDGF) RECEPTOR SIGNALING IN HUMAN RENAL CELL CARCINOMA−INDUCED MESENCHYMAL STEM CELL MIGRATION,2011 SBUR Fall Symposium,Las Vegas, Nevada USA,2011.11.10~2011.11.13, | 2011 . 11 |
48 | Analysis of a Cooperative Physician-Pharmacist Medication Therapy Management Service in Elderly Patients with Polypharmacy,gerontolrgy & geriatrics 2011,Melbourne Australia,2011.10.23~2011.10.27, | 2011 . 10 |
49 | Medication-related problems among elderly patients receiving integrated medical care service,gerontolrgy & geriatrics 2011,Melbourne Australia,2011.10.23~2011.10.27, | 2011 . 10 |
50 | 中部某醫學中心使用顯影劑引起藥物不良反應之回溯性評估,社團法人臺灣臨床藥學會100年度第12屆第2次會員代表大會暨學術研討會,中國醫藥大學,2011.09.25~2011.09.25, | 2011 . 09 |
51 | Evaluation of low urinary tract symptoms and life quality in the patient with urothelial carcinoma in bladder underwent radical cystectomy with orthotopic neobladder,泛太平洋尿控制協會年會(PPCS),台北榮總,2011.09.23~2011.09.24, | 2011 . 09 |
52 | Development of Nomorgram to Predict Pathologic outcome of radical prostatectomy for localized prostate cancer base on Taiwanese data. Annual meeting of Tiawan Urological Association.,台灣泌尿科醫學會2011年年會,成大,2011.08.13~2011.08.14, | 2011 . 08 |
53 | ,100年度台灣泌尿科年會,台南成功大學,2011.08.13~2011.08.14, | 2011 . 08 |
54 | MENINGITIS-RETENTION SYNDROME: A CASE REPORT,台灣泌尿科醫學會年會,台南成大醫學院,2011.08.13~2011.08.14, | 2011 . 08 |
55 | METACHRONOUS CANCER OF THE HEAD AND NECK AND THE URINARY TRACT,台灣泌尿科醫學會年會,台南成大醫學院,2011.08.13~2011.08.14, | 2011 . 08 |
56 | Active Monitoring of Adverse Drug Reactions Due to Use Contrast Media - A 2000-Bed Medical Center Experience in Taiwan,27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management,Chicago, Illinois, USA,2011.08.14~2011.08.17, | 2011 . 08 |
57 | Evaluation of low urinary tract symptoms and life quality in the patient with urothelial carcinoma in bladder s/p radical cystectomy with studer pouch reconstruction,台灣泌尿科醫學會年會,台南成大醫學院,2011.08.13~2011.08.14, | 2011 . 08 |
58 | Z-duugs use in elderly,Tawian Association of Gerontology and Geriatrics,Taipei, Taiwan,2011.06.05~2011.06.05, | 2011 . 06 |
59 | Z-DRUGS USE IN ELDERLY 老年人Z-DRUGS的使用,第十屆第3次會員大會暨學術研討會,台大醫學院101.102.103講堂,2011.06.05~2011.06.05, | 2011 . 06 |
60 | Trends of health care utilization among loyal patients in a medical center under Taiwan's universal health insurance program,ISPOR 16th Annual International Meeting,Baltimore, USA,2011.05.21~2011.05.25, | 2011 . 05 |
61 | The impact of integrated medical care services for loyal patients in a 2000-bed medical center under Taiwan's universal health insurance program,ISPOR 16th Annual International Meeting,Baltimore, USA,2011.05.21~2011.05.25, | 2011 . 05 |
62 | Platelet derived growth factor AA mediated the tropism of human mesenchymal stem cells for renal cell carcinoma,AACR 102nd Annual Meeting,Orlando, FL USA,2011.04.02~2011.04.06, | 2011 . 04 |
63 | The genetic role of cyclooxygenase 2 in Taiwan prostate cancer patients,第二屆調適醫學聯合學術年會,臺北市立體育學院,2011.04.09~2011.04.10, | 2011 . 04 |
64 | Associations of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer,第 26 屆生物醫學聯合學術年會,國防醫學院致德廳一樓,2011.03.19~2011.03.20, | 2011 . 03 |
65 | Nickel(II) chloride causes pancreatic islet beta-cell death via a JNK-regulated mitochondrial apoptotic pathway,The 50th Annual Meeting of the Society of Toxicology,美國,華盛頓,2011.03.06~2011.03.10, | 2011 . 03 |
66 | Low-dose pyrrolidine dithiocarbamate/copper complex induces lung epithelial cell apoptosis via the mitochondria- and ER-stress-related signaling pathways,The 50th Annual Meeting of the Society of Toxicology,美國,華盛頓,2011.03.06~2011.03.10, | 2011 . 03 |
67 | An anti-hyperglycemic effect of extract isolated from seed of Benincasa hispida extract (SBE) in high fat diet-induced type II diabetic mice,第26屆生物醫學聯合學術年會,國防醫學大學,2011.03.19~2011.03.20, | 2011 . 03 |
68 | THE MECHANISMS OF PARAQUAT-INDUCED LUNG TOXICITY IN VIVO AND IN VITRO,The 50th Annual Meeting of the Society of Toxicology,美國,華盛頓,2011.03.06~2011.03.10, | 2011 . 03 |
69 | THE IMPROVEMENT OF ADVERSE DRUG REACTIONE REPORTING SYSTEM IN A 2000-BED MEDICAL CENTER IN TAIWAN,2010 FAPA CONGRESS IN TAIPEI, TAIWAN,臺北國際會議中心,2010.11.05~2010.11.08, | 2010 . 11 |
70 | The improvement of Adverse Drug Reactions Reporting System in a 2000-bed medical center in Taiwan,The 23rd Federation of Asian Pharmaceutical Associations Congress (FAPA 2010),臺北國際會議中心 (TICC) 臺北市信義路五段一號,2010.11.05~2010.11.08, | 2010 . 11 |
71 | 中部某醫學中心病患使用顯影劑引起藥物不良反應探討,99年度台灣臨床藥學會第12屆第一次會員代表大會暨學術研討會,台北榮民總醫院,2010.10.24~2010.10.24, | 2010 . 10 |
72 | 中國醫藥大學醫學生對以問題為基礎的學習法的觀點,2010年第一屆亞太地區PBL聯合學術研討會,私立天主教輔仁大學醫學院,2010.10.22~2010.10.25, | 2010 . 10 |
73 | 中部某醫學中心病患使用顯影劑引起藥物不良反應探討,財團法人臺灣臨床藥學會第十二屆第一次會員代表大會暨學術研討會,台北榮民總醫院,2010.10.24~2010.10.24, | 2010 . 10 |
74 | Student perspectives on hybrid problem-based learning (PBL) curriculum at China Medical University in Taiwan.,the 1st Asia-Pacific Joint PBL conference 2010 Joint Conference of APC PBL and APA PHS,Taipei, Taiwan,2010.10.22~2010.10.25, | 2010 . 10 |
75 | 含碘顯影劑與含metformin成分藥品併用之風險評估,99年度台灣臨床藥學會第12屆第一次會員代表大會暨學術研討會,台北榮民總醫院,2010.10.24~2010.10.24, | 2010 . 10 |
76 | 臨床系列實證研究-以微創全子宮切除術為例,台灣實證醫學會2010學術年會,臺中榮民總醫院,2010.09.04~2010.09.04, | 2010 . 09 |
77 | The Evaluation of ADR Online Reporting of Radiopaque Agents in a University Hospital in Taiwan,ISPOR (International Society for Pharmacoeconomics and Outcomes Researc) 4th Asia-Pacific Conference,Phuket, Thailand,2010.09.05~2010.09.07, | 2010 . 09 |
78 | THE EFFECTS OF TESTOSTERONE ON THE SECRETION OF INSULIN,第10屆亞洲泌尿科醫學會議(10th Asian Congress of Urology of the Urological Association of Asia),台北國際會議中心,2010.08.27~2010.08.31, | 2010 . 08 |
79 | ,亞洲暨台灣泌尿科年會,台北國際會議中心,2010.08.27~2010.08.31, | 2010 . 08 |
80 | Penile veins are the Determining Contributor for Erection: The Hemodynamic Evidence from the Study in Defrosted Human Cadavers,12th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine,新加坡Singapore,2009.12.12~2009.12.15, | 2009 . 12 |
81 | WOMEN URINATE IN THE STANDING POSITION DO NOT INCREASE POST-VOID RESIDUAL URINE VOLUMES,台灣婦女泌尿暨骨盆醫學會(TUGA)論文發表會,台北 新北投龍邦橋園會館5樓會議室,2009.12.26~2009.12.27, | 2009 . 12 |
82 | An inducible Mesenchymal Stem Cell-based Gene Delivery System for Renal Cell Carcinoma Targeted Therapy,SBUR 2009 Annual Meeting,New Orleans, Louisiana, USA,2009.11.05~2009.11.08, | 2009 . 11 |
83 | Erlotinib(Tarceva)引起痤瘡樣皮疹之藥物不良反應案例探討,2009年社團法人台灣臨床藥學會年會暨學術研討會,財團法人彰化基督教醫院,2009.09.27~2009.09.27, | 2009 . 09 |
84 | LOWER URINARY TRACT SYMPTOMS IN THE PATIENTS WITH DEPRESSION OR ANXIETY,第四屆泛太平洋尿控制學會年會,日本福岡,2009.09.10~2009.09.10, | 2009 . 09 |
85 | 注射Indomethacin治療早產兒動脈導管閉鎖不全導致低血糖案例報告,2009年社團法人台灣臨床藥學會年會暨學術研討會,財團法人彰化基督教醫院,2009.09.27~2009.09.27, | 2009 . 09 |
86 | IS IT POSSIBLE FOR PERITONEAL DIALYSIS UREMIC PATIENTS WHO CONTINUE TO DO P.D. AT PERI-NEPHRECTOMY PERIOD?,98年度台灣泌尿科醫學會年會,高榮,2009.08.29~2009.08.30, | 2009 . 08 |
87 | Depression, anxiety and LUTS,2009 台灣LUTS研究高峰會,花蓮慈濟醫院,2009.08.15~2009.08.15, | 2009 . 08 |
88 | Spontaneous Rupture of Conventional Renal Cell Carcinoma,台灣泌尿科醫學會2009年學術演講會,高雄榮總,2009.08.29~2009.08.30, | 2009 . 08 |
89 | Comparison the difference about the clinical presentations between one stage and two stage percutaneous nephrostomy lithotripsy.,98年度台灣泌尿科醫學會年會,高榮,2009.08.29~2009.08.30, | 2009 . 08 |
90 | DOES PARTIAL CATHETER REPLACEMENT BECOME A FINAL TECHNIQUE TO OVERCOME P.D. TUNNEL INEFCTION TO MAINTAIN CATHETER SET FUNCTIONING?,98年度台灣泌尿科醫學會年會,高榮,2009.08.29~2009.08.30, | 2009 . 08 |
91 | 以創新性單一傷口腹腔鏡膀胱切開取石手術及人工網膜疝氣修補手術治療一罕見巨大膀胱結石合併單側腹股溝疝氣:一病例報告(Vedio presentation),98年第16屆第2次會員大會暨第31次學術演講會,高雄榮民總醫院(高雄市大中一路386號,2009.08.29~2009.08.30,以創新性單一傷口腹腔鏡膀胱切開取石手術及人工網膜疝氣修補手術治療一罕見巨大膀胱結石合併單側腹股溝疝氣:一病例報告 | 2009 . 08 |
92 | LOWER URINARY TRACT SYMPTOMS IN THE PATIENTS WITH DEPRESSION OR ANXIETY,98台灣泌尿科醫學會年會,高雄榮總,2009.08.28~2009.08.29, | 2009 . 08 |
93 | Significant Association of XRCC4 Genotypes with Prostate Cancer Risk in Taiwan,2009年研究學習群期末成果發表會,立夫教學大樓105講堂,2009.06.05~2009.06.05, | 2009 . 06 |
94 | Significant Association of XRCC4 Genotypes with Prostate Cancer Risk in Taiwan,第二屆中國醫藥大學暨亞洲大學生物科技研討會,立夫教學大樓B1國際會議廳,2009.03.16~2009.03.16, | 2009 . 03 |
95 | Significant Association of XRCC4 Polymorphisms with Prostate Cancer Risk in Taichung,第二十四屆生物醫學聯合學術年會,國防醫學院內湖院區,2009.03.21~2009.03.22, | 2009 . 03 |
96 | Targeting cell adhesion molecule L1 expression in bone metastatic prostate cancer cells suppresses tumor growth and metastasis by blocking mesenchymal-epithelial transition,Advances in Prostate Cancer Research,San Diego, California USA,2009.01.21~2009.01.24, | 2009 . 01 |
97 | 長期使用Rosiglitazone引起貧血之不良反應報告,九十七年度臺灣藥學會與臺灣臨床藥學會聯合年會,國防醫學院,2008.11.22~2008.11.22, | 2008 . 11 |
98 | 長期使用Rosiglitazone 引起貧血之不良反應案例報告,九十七年度台灣藥學會與臺灣臨床藥學會聯合年會,國防醫學院,2008.11.22~2008.11.22, | 2008 . 11 |
99 | Sitting and Crouching Over the Public Toilet Seat and Its Effect on Maturation,International Urogynecological Association 33rd Annual Meeting,Taipei International Convention Center(TICC) Taipei, Taiwan,2008.09.13~2008.09.17, | 2008 . 09 |
100 | VOIDING DYSFUNCTION IN MENTALLY DISABLED CHILDREN,第三屆泛太平洋尿控協會年會,高雄長庚醫院,2008.09.26~2008.09.27, | 2008 . 09 |
101 | An Online Expert System with Auto-computation on Heterogeneous Evidence-Based Data for Real Time Decision Support of Prostate Cancer Treatment,台灣實證醫學學會2008學術年會,國立成功大學醫學院,2008.09.20~2008.09.20, | 2008 . 09 |
102 | THE ROLE OF HISTOLOGICAL ANALYSIS OF CIRCUMCISION SPECIMENS,97年台灣泌尿科醫學會年會,輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
103 | Comparison of RRP and LRRP: a follow-up of 66 patients- CMCH Experiments,台灣泌尿科年會 ( 97年),台北輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
104 | DEVELOPMENT OF WEB-BASED ONLINE ANALYSIS AND DECISION SYSTEM PLATFORM FOR CLINICAL INFOMETRICS FOR PROSTATE CANCER (CIPC) AND QUALITY OF LIFE MEASUREMENT,97年度台灣泌尿科醫學會年會,輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
105 | OUTCOMES ANALYSIS OF HAND-ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY VERSUS PURE LAPAROSCOPIC NEPHROURETERECTOMY FOR MANAGING UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA—CHINA MEDICAL,2008臺灣泌尿科醫學會年會,輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
106 | LAPAROSCOPIC PARTIAL CYSTECTOMY FOR BLADDER TCC WITH MUSCLE INVASION– A CASE REPORT,97年度泌尿科醫學會年會,輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
107 | 攝護腺癌臨床資訊暨生活品質測量線上分析決策系統之資訊網路平台開發,台灣泌尿科醫學會第30次學術演講會,輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
108 | COMPARISON OF RRP AND LRRP: A FOLLOW-UP OF 86 PATIENTS-CMUH EXPERIMENTS,97年度台灣泌尿科醫學會年會,輔仁大學醫學院,2008.08.30~2008.08.31, | 2008 . 08 |
109 | Prostate Cancer Susceptibility is Associated with a Novel XPD Polymorphism in Taiwanese Patients.,2008 International Conference on Biomedicine & Graduate Student Retreat,中國醫藥大學立夫教學大樓B1 國際會議廳,2008.05.01~2008.05.02, | 2008 . 05 |
110 | A Novel Single Nucleotide Polymorphism in XPD Gene is Associated with Prostate Cancer in Central Taiwan Patients,第一屆中國醫藥大學生物科技研討會,立夫大樓B1國際會議廳,2008.04.07~2008.04.07, | 2008 . 04 |
111 | Curriculum reform for the ethical education in a medical school,International Symposium on Health Sciences Education(ISHSE 2008),China Medical University,2008.04.26~2008.04.27, | 2008 . 04 |
112 | On Emotional Sensitivity and Recruitment of Medical Students,International Symposium on Health Sciences Education.,Taichung, Taiwan,2008.04.26~2008.04.27, | 2008 . 04 |
113 | Voiding dysfunction in mentally disabled children,台灣外科醫學會 2008年年會,高雄榮民總醫院,2008.03.29~2008.03.30, | 2008 . 03 |
114 | Routine Biopsy for the Upper Urinary Tract Malignancy in Patients with Staghorn Stone,23th Annual EAU Congress,Milan, Italy,2008.03.26~2008.03.29, | 2008 . 03 |
115 | Association of XPD Polymorphisms with Prostate Cancer in Taiwanese Patients,第23屆生物醫學聯合學術年會,國防醫學院內湖院區,2008.03.29~2008.03.30, | 2008 . 03 |
116 | Primitive Neuroectodermal Tumor in Horseshoe Kidney,台灣外科醫學會第二十一屆第一次會員代表大會暨第六十七次聯合學術研討會,高雄榮民總醫院,2008.03.29~2008.03.30, | 2008 . 03 |
117 | Schedule Effect and Laparoscopic-Assisted Vaginal Hysterectomy,2007Asia Pacific Evidence-Based Medicine Network Conference,Taipei,2007.11.16~2007.11.18, | 2007 . 11 |
118 | Teaching EBM(II) & Others,亞太實證醫學聯盟研討會,台北,2007.11.16~2007.11.18, | 2007 . 11 |
119 | ,2007 Asia pacific Evidence-based medicine network conference,Taipei,2007.11.16~2007.11.18, | 2007 . 11 |
120 | Experience in teaching EBM in China Medical University,2007 Asia Pacific Evidence-Based Medicine Network conference,Taipei, 台大國際會議中心,2007.11.16~2007.11.18, | 2007 . 11 |
121 | Association of XPD Polymorphisms with Prostate Cancer in Taiwanese Patients,第一屆國際癌症學術研討會,立夫教學大樓國際會議廳,2007.11.16~2007.11.17, | 2007 . 11 |
122 | The evaulation of lower urinary tract symptoms and urodynamic studies in the patients with lumbar intervertebral disk protrudion underwent decompressive surgery,: short-term result,第二屆泛亞太平洋尿失禁協會年會,韓國首爾,2007.10.19~2007.10.19, | 2007 . 10 |
123 | 影響高科技醫療利用相關因素─以體外震波碎石術(ESWL)為例,2007台灣公共衛生學會、台灣流行病學學會聯合年會,中國醫藥大學,2007.10.06~2007.09.07, | 2007 . 10 |
124 | ,實證醫學研討會暨運用工作坊,台中中國醫藥大學,2007.09.19~2007.09.19, | 2007 . 09 |
125 | External Genital Screen for the Male Newborns in China Medical University Hospital,台灣泌尿科醫學會96年年會,台中市,2007.08.25~2007.08.26, | 2007 . 08 |
126 | THE EVALUATION OF LOWER URINARY TRACT SYMPTOMS AND URODYNAMIC STUDIES IN THE PATIENTS WITH LUMBER INTERVERTEBRAL DISK PROTRUSION UNDERWENT DECOMPRESSIVE SURGERY: SHORT-TERM RESULT,台灣泌尿科醫學會 96年年會,台中榮總,2007.08.25~2007.08.26, | 2007 . 08 |
127 | 腎臟血管平滑肌脂肪瘤的預後評估-中國醫藥大學的經驗,2007臺灣泌尿科醫學會年會,台中榮總,2007.08.25~2007.08.26, | 2007 . 08 |
128 | Initial 40 experiences of The Potassium-Titanyl-Phosphate Laser Vaporization Prostatectomy,台灣泌尿科醫學會年會,中榮,2007.08.25~2007.08.26, | 2007 . 08 |
129 | Superfical Urinary Bladder Urolthelial Carcinoma in Uremic Patients,台灣泌尿科醫學會96年度第29次學術演講會,台中榮總,2007.08.25~2007.08.26, | 2007 . 08 |
130 | Radical Cystectomy in Elderly: Clinical Result and Long-term Follow-up,台灣泌尿科醫學會96年度第29次學術演講會,台中榮總,2007.08.25~2007.08.26, | 2007 . 08 |
131 | 以經尿道肉毒桿菌素注射膀胱頸治療年紀小於50歲之原發性膀胱頸阻塞病人:短期報告,台灣外科醫學會年會,台灣高雄(榮總),2007.03~ , | 2007 . 03 |
132 | Using Transurethral Botulinum Toxin Injection Of Bladder Neck For The Treatment Of Primary Bladder Neck Obstruction In Men Less Than 50 Years Of Age: Short-Term Result,中華民國外科醫學會2007年年會,高雄榮總,2007.03.24~2007.03.25, | 2007 . 03 |
133 | Proteomic study of HM-1 inhibits angiogenesis by disrupting microtubules on human umbilical vein endothelial cells,The 22th Joint Annual Conference of Biomedical Sciences,Taipei,2007.03.17~2007.03.18, | 2007 . 03 |
134 | Proteomic Analysis of Protein Expression Profiles in Anti-metastasis Mechanism of the SCK-2231 on PC-3 Prostate Cells,The 22th Joint Annual Conference of Biomedical Sciences,國防大學國防醫學院,2007.03.17~2007.03.18, | 2007 . 03 |
135 | Proteomic Analysis of Protein Expression Profiles in Anti-metastasis Mechanisms of the SCK-2231 on PC-3 Prostate Cancer Cells,The 22th Joint Annual Conference of Biomedical Sciences.,Taipei,2007.03.17~2007.03.18, | 2007 . 03 |
136 | ,Cochrane library實証資料庫推廣計劃說明會,台中,2007.02.07~2007.02.07,院內推展實証醫學學術活動實例分享 | 2007 . 02 |
137 | 人文關懷的提升:以中國醫藥大學「病人關懷與實踐課程」的經驗為例,第九屆海峽兩岸暨香港地區醫學教育研討會 Oct-06,四川成都,2006.10.05~2006.10.06, | 2006 . 10 |
138 | 病人關懷與實踐課程的效果評價,海峽兩岸醫學教育研討會,中國大陸四川,2006.10.20~2006.10.25, | 2006 . 10 |
139 | 人文關懷的提升:以中國醫藥大學「病人關懷與實踐課程」的經驗為例,第九屆海峽兩岸暨香港地區醫學教育研討會,中國成都,2006.10~ , | 2006 . 10 |
140 | Using transurethral botulinum toxin injection of prostate for the treatment of benign prostate hyperplasia: short-term result,泛太平洋尿控制協會2006年會,日本 /東京,2006.09.05~2006.09.06, | 2006 . 09 |
141 | Using Transurethral Botulinum Toxin Injection Of Prostate For The Treatment Of Benign Prostate Hyperplasia: Short-Term Result,第一屆泛太平洋下泌尿道功能障礙研討會,日本東京,2006.09.06~2006.09.06, | 2006 . 09 |
142 | The surgical results of renal cell carcinoma at CMUH,台灣泌尿科醫學會年會(國內/台灣 /台北) Aug-06,國內/台灣 /台北,2006.08.05~2006.08.06, | 2006 . 08 |
143 | Left ectopic ureteral orifice located on the bladder neck- internal sphincter: case report,台灣泌尿科醫學會95年年會(,台灣台北,2006.08~ , | 2006 . 08 |
144 | Using Transurethral Resection Of Prostate And Botulinum Toxin Injection Of External Sphincter For The Treatment Of Benign Prostate Hyperplasia And Detrusor-Sphincter Dyssynergia,95年泌尿科年會,高雄榮總,2006.08.25~2006.08.26, | 2006 . 08 |
145 | Four-corner autologous rectus fascia sling procedure for repair of anterior vaginal prolapse,台灣泌尿科醫學會95年年會,台灣台北,2006.08~ , | 2006 . 08 |
146 | Outcome of the Urinary Bladder after Bilateral Nephroureterectomy in Uremic Patients with Urolthelial Carcinoma,台灣泌尿科醫學會95年年會,台灣台北,2006.08~ , | 2006 . 08 |
147 | 尿毒症病人的續發性對側上泌尿道泌尿上皮癌,台灣泌尿科醫學會95年年會,台灣台北,2006.08~ , | 2006 . 08 |
148 | Camparison of open and laparoscopic bilateral nephroureterectomy and cystectomy in uremic patients,台灣泌尿科醫學會年會,台灣台北,2006.08~ , | 2006 . 08 |
149 | Using transurethral Botulinum Toxin injection of prostate for the treatment of benign Prostate Hyperplasia: shout-term result,台灣泌尿科醫學會95年年會,台灣台北,2006.08~ , | 2006 . 08 |
150 | Using transurethral botulinum toxin injection of prostate for the treatment of benign prostate hyperplasia: short-term result,泛太平洋尿控制協會年會,日本東京,2006.08~ , | 2006 . 08 |
151 | Subsequent contralateral upper urinary tract urothelial carcinoma in uremic patients,95年台灣泌尿科醫學會年會,TaiwanTaipei,2006.08~ , | 2006 . 08 |
152 | The efficacy of emergent embolizaton of internal iliac artery for severe hemorrhagic radiation cystitis,台灣泌尿科醫學會年會,台灣台北,2006.08~ , | 2006 . 08 |
153 | USING TRANSURETHRAL BOTULINUM TOXIN INJECTION OF PROSTATE FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA: SHORT-TERM RESULT,95年泌尿科年會,台灣,2006.08.23~2006.08.24,USING TRANSURETHRAL BOTULINUM TOXIN INJECTION OF PROSTATE FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA: SHORT-TERM RESULT | 2006 . 08 |
154 | The surgical results of renal cell carcinoma at CMUH,台灣泌尿科醫學會年會,台灣台北,2006.08~ , | 2006 . 08 |
155 | Biopsy of renal pelvis during the percutaneous nephrolithotripsy session,台灣泌尿科醫學會95年年會,台灣台北,2006.08~ , | 2006 . 08 |
156 | Outcome of the urinary bladder after bilateral nephroureterectomy in uremic patients with urothelial carcinoma,95年台灣泌尿科醫學會年會,TaiwanTaipei,2006.08~ , | 2006 . 08 |
157 | An aged female urethra inverted papilloma — case report,台灣泌尿科醫學會95年年會,台灣台北,2006.08~ , | 2006 . 08 |
158 | Combined Botulinum-A Toxin Injections on the External Urethral Sphincter and TURP for the Treatment for the Patients with BPH and HIVD,中華民國外科醫學會2006年年會,林口 長庚醫學院,2006.03.26~2006.03.27, | 2006 . 03 |
159 | Using transurethral resection of prostate and botulinum toxin injection of external sphincter for the treatment of benign prostate hyperplasia and detrusor-sphincter dyssynergia,台灣外科醫學會年會,台灣桃園,2006.03~ , | 2006 . 03 |
160 | The result of calycoureterostomy: follow up-cases report,台灣外科醫學會年會,台灣台北,2006.03~ , | 2006 . 03 |
161 | Incorporating evidence based medicine into decision-making process for formulary: which colloid is best for resuscitation?,亞太地區實證醫學與臨床診療指引國際研討會,台灣台北,2005.12~ , | 2005 . 12 |
162 | Botulinum-A Toxin injections on the external urethral sphincter as a treatment for voiding dysfunctionof women,台灣尿失禁防治協會及中華民國婦女泌尿暨骨盆鬆弛醫學會聯合年會,台灣台北市,2005.12~ , | 2005 . 12 |
163 | Cerebrovascular accident and urine retention: a prospective correlation of the site of brain injury with urodynamic studies,The 2nd Japan - Korea joint meeting on lower urinary tract dysfucntion,韓國首爾,2005.10~ , | 2005 . 10 |
164 | RADICAL CYSTECTOMIES: A REVIEW OF CHINA MEDICAL UNIVERSITY EXPERIENCE,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.08~ , | 2005 . 08 |
165 | CHARACTERISTIC PATTERNS ON MASS SPECTROSCOPY OF PROTEINS EXTRACTED FROM CALCIUM OXALATE STONES,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.08~ , | 2005 . 08 |
166 | Incidental upper urinary tract malignancy found in non-function kidney caused by urolithiasis,World congress on Endourology & ESWL,荷蘭陳姆斯特丹,2005.08~ , | 2005 . 08 |
167 | CYSTECTOMIES IN UREMIA PATIENTS: WHAT IS DIFFERENCE,94年度第14屆第2次會員大會暨第27次學術演講會,台灣高雄,2005.08~ , | 2005 . 08 |
168 | Incidental upper urinary tract malignancy found in non-function kidney caused by urolithiasis,23rd World Congress on Endourology and SWL 21st Basic Research Symposium,荷蘭阿姆斯特丹,2005.08~ , | 2005 . 08 |
169 | Antireflux Surgery of Vesicoureteral Reflux : Experience in China Medical University Hospital,94年台灣外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
170 | Prevalence study of ault hypogonadism in taiwan.,94年台灣男性學醫學會年會,台灣台北,2005.03~ , | 2005 . 03 |
171 | Extrarenal malignant rhabdoid tumor from omentum in an adult : case report,94年外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
172 | Gangrenous cystitis : case report,94年外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
173 | Laparoscopic Radical Prostatectomy:CMUH Initial Experience,台灣外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
174 | Laparoscopic radical prostatectomy : China Medical Univirsity Hospital initial experience,94年外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
175 | Risk Adjustment for evaluating the outcome of urological operation,94年外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
176 | The use of self-made prolene mesh sling for the treatment of patients with strress urinary incontinence,外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
177 | Gangrenous cystitis : case report,94年外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
178 | The Surgical Treatment for adrenal tumor causing cushing's syndrome,94年外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
179 | Bilateral testicular infarction due to thromboembolism of lung cancer,94年外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
180 | Prevlence Study of adult Hypogonadism in Taiwan,94年度台灣男性學醫學會,台灣台北,2005.03~ , | 2005 . 03 |
181 | Antireflux surgery of vesicoureteral reflux : experience in China Medical University Hospital,台灣外科醫學會第19屆第2次會員代表大會暨第64次學術演講會,長庚大學,2005.03.27~2005.03.27, | 2005 . 03 |
182 | Laparoscopic radical prostatectomy : China Medical Univirsity Hospital initial experience,94年外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
183 | Laparoscopic nerve sparing radical prosatectomy,94年度台灣男性學醫學會年會,台灣台北,2005.03~ , | 2005 . 03 |
184 | Prevalence Study of Adult Hypogonadism in Taiwan,台灣外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
185 | Extrarenal malignant rhabdoid tumor from omentum in an adult : case report,94年外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
186 | The Surgical Treatment for adrenal tumor causing cushing's syndrome,94年外科醫學會年會,台灣台北縣,2005.03~ , | 2005 . 03 |
187 | Bilateral testicular infarction due to thromboembolism of lung cancer,94年外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
188 | Risk adjustment for evaluating the outcome of urological operation,94年外科醫學會年會,台灣桃園縣,2005.03~ , | 2005 . 03 |
189 | THE USE OF SELF-MADE PROLENE MESH SLING FOR THE TREATMENT OF PATIENTS WITH STRESS URINARY INCONTINENCE,94年外科醫學會年會,長庚醫學大學,2005.03.26~2005.03.27, | 2005 . 03 |
190 | 以實證醫學(EBM)的方法評析更年期荷爾蒙療法原著論文-Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women JAMA. 2002; 288:321-333,The 3rd Asia Pacific Conference on Evidence-Based Medicine第三屆亞太循證醫學大會,中國 香港香港,2004.11~ , | 2004 . 11 |
191 | Using alpha adrenergic antagonists and urethral sounding for the treatment of bladder outlet obstruction of women,台灣尿失禁防治協會及中華民國婦女泌尿暨骨盆鬆弛醫學會聯合年會,台灣台北,2004.10~ , | 2004 . 10 |
192 | Experience in teaching ebm in china medical university hospital.,第三屆亞太循證醫學大會,中國香港,2004.10~ , | 2004 . 10 |
193 | Right perirenal and retroperitoneal fluid collection: suspected pancreatic pseudocyst rupture--case report.,93年泌尿科年會暨醫學會,台灣台北,2004.08~ , | 2004 . 08 |
194 | Pure laparoscpic left live donor nephrectomy-initial experience and its technical consideration.,93年泌尿科年會暨醫學會,台灣台北,2004.08~ , | 2004 . 08 |
195 | Left xanthogranulotamous pyelonephritis with left-sided inferior vena cava: report of a case.,93年台灣泌尿科醫學會年會,台灣台北,2004.08~ , | 2004 . 08 |
196 | Using alpha adrenergic antagonists and urethral sounding for the treatment of bladder outlet obstruction of women.,93年台灣泌尿科醫學會,台灣台北,2004.08~ , | 2004 . 08 |
197 | RIGHT PERIRENAL AND RETROPERITONEAL FLUID COLLECTION:,泌尿外科醫學會年度學術討論會,中國醫藥大學,2004.08.28~2004.08.29, | 2004 . 08 |
198 | USING ALPHA ADRENERGIC ANTAGONISTS AND URETHRAL SOUNDING FOR THE TREATMENT OF BLADDER OUTLET OBSTRUCTION OF WOMEN,93年台灣泌尿科醫學會年會,中國醫藥大學,2004.08.28~2004.08.29, | 2004 . 08 |
199 | The experience of laparoscopic surgery for the suprarenal lesions in the cmuh.,93年泌尿科年會醫學會,台灣台北,2004.08~ , | 2004 . 08 |
200 | Case report: accessory spleen Mimics a left adrenal tumor.,台灣泌尿科醫學會93年度大會,台灣台北,2004.08~ , | 2004 . 08 |
201 | Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction: initial experience.,93年度台灣外科醫學會,台灣台北,2004.03~ , | 2004 . 03 |
202 | Renal transplantation: limited experience from CMUH,九十三年外科醫學會,台灣台北,2004.03~ , | 2004 . 03 |
203 | Tadalafil對台灣男性勃起障礙患者的治療效果,93年度台灣男性學醫學會年會,台灣台南,2004.03~ , | 2004 . 03 |
204 | The use of in situ anterior vaginal wall sling for the treatment of grade III-IV cystocele with stress urinary incontinence,九十三年外科醫學會,台灣台北,2004.03~ , | 2004 . 03 |
205 | Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction: initial experience,九十三年外科醫學會,台灣台北,2004.03~ , | 2004 . 03 |
206 | Low dose dexamethasone therapy for hormone refractory prostate cancer,九十三年外科醫學會,台灣台北,2004.03~ , | 2004 . 03 |
207 | Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction: initial experience,93年度台灣外科醫學會,台灣台北,2004.03~ , | 2004 . 03 |
208 | The Use of in Situ Anterior Vaginal Wall Sling for the Treatment of Grade III-IV Cystocele With Stress Urinary Incontinence,93年外科醫學會年會,長庚大學,2004.03.28~2004.03.29, | 2004 . 03 |
209 | Tadalafil improves erectile function in Taiwanese men with erectile dysfunction,9th Biennial Meeting of the Asia Pacific society for Sexual and Impotence Research,菲律賓Cebu,2003.10~ , | 2003 . 10 |
210 | 某醫學中心藥物不良反應通報分析,社團法人中華民國臨床藥學會第九屆第一次會員代表大會暨學術研討會,台北,2003.10~ , | 2003 . 10 |
211 | Prognostic Factors of Biochemical Failure after Radical Prostatectomy.,台灣泌尿科醫學會92年會員大會,中國醫藥大學,2003.08.30~2003.08.31, | 2003 . 08 |
212 | Use of genetic algorithms and artificial neural networks to the prediction of stone disease by clinical parameters and genetic polymorphisms<BR>,台灣泌尿科學會,,2003.08~ , | 2003 . 08 |
213 | Comparison with Incidental Detected and Symptomatic Renal Cell Carcinoma.,台灣泌尿科醫學會92年會員大會,中國醫藥大學,2003.08.30~2003.08.31, | 2003 . 08 |
214 | Transitional cell carcinoma in uremic patients,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
215 | New technique treated forgotten indwelling ureteral stent with silk-loop fixed its low end<BR>,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
216 | Surgery treatment for upper urinary tract TCC,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
217 | Paclitaxel (Taxol) induced G2/M arrest of cell cycle in human bladder cancer cell line (T24)<BR>,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
218 | Congenital Ureteropelvic Junction Obstruction: Experience in CMUH.,台灣泌尿科醫學會92年會員大會,中國醫藥大學,2003.08.30~2003.08.31, | 2003 . 08 |
219 | Neoadjuvant Androgen Deprivation and Definitive Radiotherapy in Localized and Locally Advanced Prostate Cancer,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
220 | Laparoscopic surgery for upper urinary tract tcc-preliminary experiences in china medical college hospital<BR>,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
221 | The applied evaluation of retrograde pyelographyhe for patients with hematuria<BR>,台灣泌尿科醫學會,,2003.08~ , | 2003 . 08 |
222 | ,台灣外科醫學會92年會員大會,高醫,2003.03.29~2003.03.30,Vascular Endothelial Growth Factor Gene –460 C/T Polymorphism Is a Biomarker for Prostate Cancer | 2003 . 03 |
223 | Leiomyoma of the bladder neck—An unusual cause of difficult voiding.,中華民國泌尿科醫學會92年會員大會,北榮,2002.08.24~2002.08.25, | 2002 . 08 |
224 | Upper Urinary Tract Tumor Coexisted with Urollithiasis.,中華民國泌尿科醫學會92年會員大會,北榮,2002.08.01~2002.08.01, | 2002 . 08 |
225 | Osteocalcin Gene Hind III C/T Polymorphism Is a Biomarker for Prostate Cancer and Responsiveness to Hormone Therapy.,中華民國泌尿科醫學會92年會員大會,北榮,2002.08.24~2002.08.25, | 2002 . 08 |
226 | Prediction of Stone Disease by Artificial Neural Networks in Genetic Polymorphism - A New Modality.,中華民國泌尿科醫學會92年會員大會,北榮,2002.08.24~2002.08.25, | 2002 . 08 |
227 | Are Penile Blood Flow Parameters by Ultrasonography Necessary in Diagnosing the Ediology of Erectile Dysfunction?,中華民國泌尿科醫學會92年會員大會,北榮,2002.08.01~2002.08.01, | 2002 . 08 |
228 | Pelvic Lipomatosis:A Case Report and Review of Literature,台灣外科醫學會92年會員大會,高醫,2002.03.24~2002.03.24, | 2002 . 03 |
229 | Assessment of the Change in Life Quality and in Sexual Activities of the Female Patient Before and after Operation for Stress Urinary Incontinence.,台灣外科醫學會92年會員大會,高醫,2002.03.24~2002.03.24, | 2002 . 03 |
230 | The Possibility of Anterior Calyx to Be an Access of PCN or PCNL,台灣外科醫學會92年會員大會,高醫,2002.03.23~2002.03.23, | 2002 . 03 |
231 | Abdominal Non-Wilms’ Tumors in Children:Experience in CMCH.,台灣外科醫學會92年會員大會,高醫,2002.03.23~2003.03.23, | 2002 . 03 |
232 | Asymptomatic Microscopic Hematuria Is Full Urological Examination Needed?,外科醫學會,高醫,2002.03.23~2002.03.23, | 2002 . 03 |
233 | Experience of Pubovaginal Sling Suspension in Treatment of Stress Urinary Incontinence.,台灣外科醫學會92年會員大會,高醫,2002.03.24~2002.03.24, | 2002 . 03 |
234 | Spontaneous Ureteral Rupture in a Patient with Urolithiasis.,台灣外科醫學會92年會員大會,高醫,2002.03.24~2002.03.24, | 2002 . 03 |
235 | Long term results of Pubo-vaginal rectus fasical slings for female stress urinary,泌尿科醫學會年會,北榮,1998.08.23~1998.08.24, | 1998 . 08 |
236 | Persistent mullerian duct syndrome report of a case and literature review,泌尿科醫學會,台灣台北市,1996.08~ , | 1996 . 08 |
237 | Immunohistochemical determination of p53 protein in prostate adenocarinoma,泌尿科醫學年會,台灣台北市,1996.08~ , | 1996 . 08 |
238 | Problem encountering in the removal of forgotten and encrusted double-J catheter,泌尿科醫學會,台灣台北市,1996.08~ , | 1996 . 08 |
239 | Percentage of free serum prostate-specific antigen in the diagnosis of prostate cancer.,泌尿科醫學會,台灣台北市,1996.08~ , | 1996 . 08 |
240 | Surgical treatment of hypospadias-personal experience in CMCH,外科醫學會年會,台灣台北市,1996.03~ , | 1996 . 03 |
241 | Cystitis cystica-its relation to urinary bladder cancer,外科醫學會,台灣台北市,1996.03~ , | 1996 . 03 |
242 | Emphysematous pyelonephritis - 4 cases report,外科醫學會年會,台灣台北市,1996.03~ , | 1996 . 03 |
243 | Mangement of urinary tract fistula,外科醫學會年會,台灣台北市,1996.03~ , | 1996 . 03 |
專書
專書/Books (作者,書名,出版商,出版日期) |
日期 | |
1 | 吳錫金(Wu,Hsi-Chin)、侯庭鏞(Tin-Yun Ho)、方世華、林振文(Lin Cheng Wen)、項千芸(Chien-Yun Hsiang)、李龍緣(Long-Yuan Li)、林應如(Ying-Ju Lin)、許晉銓(Jinn-Chyuan Sheu)、萬磊(Lei Wan)、徐媛曼(Yuan-Man Hsu)、洪千惠、湯智昕(Tang Chih-Hsin)、賴怡琪、賴志河(Chih-Ho Lai),Arthur M. Lesk: Introduction to Bioinformatics,,2008.9 | 2008 . 09 |
2 | 龔佩珍(Kung, P.T.)、蔡文正(Tsai,Wen-Chen)、吳錫金(Wu,His-Chin),影響高科技醫療利用相關因素-以體外震波碎石術(ESWL)為例,國科會研究計畫,2006.7 | 2006 . 07 |
研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,DMR-111-170,郭錦輯(Kuo, Chin-Chi)、吳錫金(Hsi-Chin Wu)、謝博帆(Hsieh, Po-Fan)、鄭奇(Chi-Fung Cheng)、巫旻諺(WU MIN-YEN)、陳聖軒(CHEN SHENG-HSUAN),附醫院內計畫,整合醫療影像與病理資訊之前列腺癌臨床大數據,2021.8.1~2022.6.30 | 2021 . 08 |
2 | 個別型,A1051222-107,邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(Tzu-Liang Chen)、柯道維(Tao-Wei Ke)、王輝明(Hwei-Ming Wang)、陳宏彰(Hung-Chang Chen)、黃郁純(Yu-Chuen Huang)、花俊宏(Chun-Hung Hua)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、吳錫金(Hsi-Chin Wu)、黃志平(Chi-Ping Huang)、蔡宗欣(Tzong-Shin Tzai)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、吳建廷(Chen-Teng Wu)、劉良智(Liang-Chih Liu)、吳曜充(Yao-Chung Wu)、陳芝蓉(Chih-Jung Chen)、鄭書(Yu-Shu Cheng)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、陳鴻仁(Hung-Jen Chen)、劉秋松(Chiu-Shong Liu)、陳毓隆(Yu-Lung Chen)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年) 107年後續擴充,2018.10.5~2019.10.4 | 2018 . 10 |
3 | 臨床試驗與研究計畫,CMUH103-REC1-126,林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、張兆祥(Chang, Chao-Hsiang)、吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei),附醫廠商計畫,一項第三期、開放標示、多中心、隨機分配之臨床試驗,比較MPDL3280A(抗PD-L1抗體)與化學治療,用於含鉑藥物化學治療無效的局部晚期或轉移性尿路上皮膀胱癌患者之療效及安全性評估,2017.1.1~2017.12.31 | 2017 . 01 |
4 | 臨床試驗與研究計畫,CMUH104-REC1-116,梁基安(Liang, Ji-An)、陳汶吉(Chen, Wen-Chi)、陳冠亨(Guang-Heng Chen)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、葉進仲(Yeh, Chin-Chung)、郭于誠(Yu-Cheng, Kuo),附醫廠商計畫,接受主要放射線療法之高風險、局限性或局部晚期攝護腺癌受試者使用JNJ-56021927的一項隨機分配、雙盲、安慰劑對照第3期研究,2017.1.1~2017.12.31 | 2017 . 01 |
5 | 臨床試驗與研究計畫,CMUH106-REC2-087,張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、張議徽(Yi-Huei Chang)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項第二期試驗,針對患有轉移性去勢療法無效之攝護腺癌,同時帶有DNA修復基因異常的男性患者,評估Niraparib的療效和安全性,2017.1.1~2017.12.31 | 2017 . 01 |
6 | 臨床試驗與研究計畫,CMUH106-REC2-121,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,PARACHUTE:Pazopanib治療各種狀況晚期腎細胞癌患者之臨床療效及安全性實務評估;一項前瞻性、非介入性、觀察性研究,2017.1.1~2017.12.31 | 2017 . 01 |
7 | 臨床試驗與研究計畫,CMUH106-REC3-010,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、林精湛(Ching-Chan Lin)、葉士芃(Yeh, Su-Peng),附醫廠商計畫,一項第III期、多中心、隨機分配、安慰劑對照、雙盲試驗,以ATEZOLIZUMAB (抗PD-L1抗體)作為輔助治療用於腎切除術後發生轉移風險偏高之腎細胞癌病患,2017.1.1~2017.12.31 | 2017 . 01 |
8 | 臨床試驗與研究計畫,CMUH105-REC3-093,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh),附醫廠商計畫,一項第三期、隨機分配、開放性試驗,評估Pembrolizumab(MK-3475)併用Axitinib相較於Sunitinib單一療法做為局部晚期或轉移性腎細胞癌第一線療法的療效和安全性(KEYNOTE-426),2017.1.1~2017.12.31 | 2017 . 01 |
9 | 臨床試驗與研究計畫,CMUH102-REC1-068,,附醫廠商計畫,PROSPER:在非轉移性去勢抗性前列腺癌病患中評估enzalutamide 療效和安全性的一項多國、第三期、隨機分派、雙盲、安慰劑對照試驗,2017.1.1~2017.12.31 | 2017 . 01 |
10 | 臨床試驗與研究計畫,CMUH106-REC3-081,張兆祥(Chang, Chao-Hsiang)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、林哲弘(Che-Hung Lin)、葉士芃(Yeh, Su-Peng),附醫廠商計畫,一項第III期、隨機分配、雙盲、安慰劑對照的多中心試驗,針對無症狀或有輕度症狀且先前未曾接受治療的轉移性去勢抗性前列腺癌成人男性患者,給予IPATASERTIB併用ABIRATERONE和PREDNISONE/PREDNISOLONE或安慰劑併用ABIRATERONE和PREDNISONE/PREDNISOLONE進行比較,2017.1.1~2017.12.31 | 2017 . 01 |
11 | 臨床試驗與研究計畫,CMUH103-REC1-038,張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、陳國樑(Chen, Kuo-Liang)、鄒頷龍、黃志平(Huang, Chi-Ping),附醫廠商計畫,第二期雙盲隨機分組安慰劑控制臨床試驗研究MCS®於預防男性前列腺癌之效果及安全性,2017.1.1~2017.12.31 | 2017 . 01 |
12 | 臨床試驗與研究計畫,CMUH103-REC2-029,張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、葉進仲(Yeh, Chin-Chung)、黃志平(Huang, Chi-Ping)、陳國樑(Chen, Kuo-Liang)、陳汶吉(Chen, Wen-Chi),附醫廠商計畫,一項亞洲、多國、第三期、隨機、雙盲、安慰劑對照、針對未曾接受化學治療且使用雄性素去除療法後失敗之漸進性轉移性攝護腺癌患者使用口服enzalutamide之療效與安全性的試驗,2017.1.1~2017.12.31 | 2017 . 01 |
13 | 臨床試驗與研究計畫,CMUH106-REC2-071,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh)、林哲弘(Che-Hung Lin)、張議徽(Yi-Huei Chang)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項第三期、隨機分配、雙盲、安慰劑對照臨床試驗,以Pembrolizumab (MK-3475) 單一療法做為腎細胞癌腎切除術後的輔助性治療(KEYNOTE-564),2017.1.1~2017.12.31 | 2017 . 01 |
14 | 個別型,NHRI-EX106-10318PC,林正介(Cheng-Chieh Lin)、李采娟(Tsai-Chung Li)、洪瑞松(Jui-Sung Hung)、吳錫金(Wu,Hsi-Chin)、洪靚娟(Chin-Chuan Hung)、林志學(Chih-Hsueh Lin)、周哲毅(Che-Yi Chou)、張欽凱(Chin-Kan Chang)、廖俊惠(Chun-Hui Liao)、張倍禎(Jane Pei-Chen Chang)、謝右文(Yow-Wen Hsieh)、林宜慧(Yi-Hui Lin)、蔡馨慧(Hsin-Hui Tsai),國衛院,老年人睡眠障礙使用安眠藥品之風險與效益評估,2017.1.1~2017.12.31 | 2017 . 01 |
15 | 臨床試驗與研究計畫,CMUH104-REC2-150,張兆祥(Chang, Chao-Hsiang)、楊啟瑞(Yang, Che-Rei)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、連啟舜(Chi-Shun Lien)、黃志平(Huang, Chi-Ping),附醫廠商計畫,一項第三期隨機研究,針對接受確定性療法後其高風險非轉移性前列腺癌仍惡化的男性患者,探討 Enzalutamide + Leuprolide 療法、Enzalutamide 單一療法及安慰劑 + Leuprolide 療法的療效和安全性,2017.1.1~2017.12.31 | 2017 . 01 |
16 | 臨床試驗與研究計畫,CMUH106-REC2-099,葉士芃(Yeh, Su-Peng)、吳錫金(Wu, Hsi-Chin)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、林哲弘(Che-Hung Lin)、林精湛(Ching-Chan Lin)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項隨機分配、雙盲、第2期試驗,評估腎細胞癌在接受一種血管內皮生長因子(VEGF)標靶治療後,使用二種不同起始劑量Lenvatinib (18mg相較於14mg QD)合併Everolimus (5mg QD)之安全性和療效,2017.1.1~2017.12.31 | 2017 . 01 |
17 | 臨床試驗與研究計畫,CMUH105-REC3-096,楊啟瑞(Yang, Che-Rei)、張兆祥(Chang, Chao-Hsiang)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、葉士芃(Yeh, Su-Peng)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin),附醫廠商計畫,ODM-201相較於安慰劑、加上標準雄性素去除療法與docetaxel使用於轉移性荷爾蒙敏感性攝護腺癌病患的一項隨機分配、雙盲、安慰劑對照第三期研究,2017.1.1~2017.12.31 | 2017 . 01 |
18 | 臨床試驗與研究計畫,CMUH105-REC2-108,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、葉進仲(Yeh, Chin-Chung)、謝博帆(Po-Fan Hsieh)、連啟舜(Chi-Shun Lien)、陳冠亨(Guang-Heng Chen)、陳汶吉(Chen, Wen-Chi)、黃志平(Huang, Chi-Ping),附醫廠商計畫,一項研究亞洲攝護腺癌病患使用 ELIGARD®的安全性、療效和生活品質之第四期、介入性試驗(ELIGANT),2017.1.1~2017.12.31 | 2017 . 01 |
19 | 臨床試驗與研究計畫,DMR100-IRB-006,,附醫廠商計畫,一項第II期、開放性試驗,針對曾經接受雄性素去除 (androgen deprivation)及背景化學藥物Docetaxel治療法失敗的晚期攝護腺癌病患,探討使用JNJ-212082 (Abiraterone Acetate)倂用Prednisolone的功效,2017.1.1~2017.12.31 | 2017 . 01 |
20 | 臨床試驗與研究計畫,CMUH104-REC2-030,張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)、 葉士芃、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin),附醫廠商計畫,一項使用Pembrolizumab (MK-3475)於晚期無法以手術切除或轉移性尿路上皮癌患者的第二期臨床試驗,2016.1.1~2016.12.31 | 2016 . 01 |
21 | 臨床試驗與研究計畫,CMUH104-REC1-116,梁基安(Ji-An Liang)、陳汶吉(Chen, Wen-Chi)、陳冠亨(Guang-Heng Chen)、楊啟瑞(Che-Rei Yang)、 黃志平、謝博帆(Po-Fan Hsieh)、葉進仲(Yeh, Chin-Chung)、郭于誠(Yu-Cheng, Kuo),附醫廠商計畫,接受主要放射線療法之高風險、局限性或局部晚期攝護腺癌受試者使用JNJ-56021927的一項隨機分配、雙盲、安慰劑對照第3期研究,2016.1.1~2016.12.31 | 2016 . 01 |
22 | 個別型,NHRI-EX105-10318PC,林正介(Cheng-Chieh Lin)、李采娟(Tsai-Chung Li)、吳錫金(Wu,Hsi-Chin)、洪靚娟(Chin-Chuan Hung)、林志學(Chih-Hsueh Lin)、謝右文(Yow-Wen Hsieh)、張欽凱(Chin-Kan Chang)、蔡馨慧(Hsin-hui Tsai)、廖俊惠(Chun-Hui Liao)、周哲毅(Che-Yi Chou),國衛院,老年人睡眠障礙使用安眠藥品之風險與效益評估,2016.1.1~2016.12.31 | 2016 . 01 |
23 | 臨床試驗與研究計畫,CMUH103-REC2-031,張兆祥(Chang,Chao-Hsiang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang),附醫廠商計畫,一項前瞻性、縱貫、多國參與、觀察性研究,描述在接受確定性攝護腺癌治療後經過生化檢測證明出現復發並具有臨床結果差的高風險的男性病人、患有抗去勢型攝護腺癌的男性病人,以及首次診斷即確定為轉移性攝護腺癌的男性病人的照護模式和結果,2016.1.1~2016.12.31 | 2016 . 01 |
24 | 臨床試驗與研究計畫,CMUH102-REC1-029,,附醫廠商計畫,一項有關晚期或轉移性腎癌病患實際接受pazopanib的治療模式與治療結果的前瞻性觀察研究,2016.1.1~2016.12.31 | 2016 . 01 |
25 | 臨床試驗與研究計畫,DMR99-IRB-141,,附醫廠商計畫,台灣區病歷回溯性研究: 治療轉移性腎細胞癌病患之血管新生抑制劑的用藥劑量、變換用藥、有效性、安全性以及醫療花費之狀況,2016.1.1~2016.12.31 | 2016 . 01 |
26 | 臨床試驗與研究計畫,CMUH104-REC2-135,楊啟瑞(Che-Rei Yang)、吳錫金(Wu,Hsi-Chin)、葉士芃(Su-Peng Yeh),附醫廠商計畫,上市後觀察性登記探討INLYTA®用於治療台灣晚期腎細胞癌患者的使用劑量、安全性及效益,2016.1.1~2016.12.31 | 2016 . 01 |
27 | 臨床試驗與研究計畫,DMR99-IRB-197,,附醫廠商計畫,一項針對需要雄性素阻斷療法的攝護腺癌台灣患者研究按月投予Degarelix劑量處方之療效與安全性的開放性、多中心、查驗登記用試驗,2016.1.1~2016.12.31 | 2016 . 01 |
28 | 臨床試驗與研究計畫,DMR100-IRB-153,,附醫廠商計畫,一個為期12週的開放 MCS-2-TWN-a的延伸性試驗,用以進一步收集以及評估 L-O-M® MCS在前列腺肥大病人治療下泌尿道症狀的安全性及效果,2016.1.1~2016.12.31 | 2016 . 01 |
29 | 臨床試驗與研究計畫,CMUH103-REC2-029,張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)、陳國樑(Chen, Kuo-Liang)、陳汶吉(Chen, Wen-Chi),附醫廠商計畫,一項亞洲、多國、第三期、隨機、雙盲、安慰劑對照、針對未曾接受化學治療且使用雄性素去除療法後失敗之漸進性轉移性攝護腺癌患者使用口服enzalutamide之療效與安全性的試驗,2016.1.1~2016.12.31 | 2016 . 01 |
30 | 臨床試驗與研究計畫,DMR98-IRB-279,,附醫廠商計畫,第三期雙盲隨機分組安慰劑控制臨床試驗研究L-O-M® MCS 於治療男性前列腺肥大新病人之下泌尿道症狀之效果及安全性。延伸性研究:為期6個月的MCS開放性延伸治療研究進一步評估L-O-M® MCS於治療男性前列腺肥大新病人之下泌尿道症狀之效果及安全性,2016.1.1~2016.12.31 | 2016 . 01 |
31 | 臨床試驗與研究計畫,CMUH103-REC1-135,張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)、葉士芃(Su-Peng Yeh)、林精湛(Ching-Chan Lin),附醫廠商計畫,一項第三期隨機臨床試驗,於患有已復發或已惡化轉移性尿路上皮癌的受試者中比較pembrolizumab(MK-3475)與paclitaxel、docetaxel或vinflunine,2016.1.1~2016.12.31 | 2016 . 01 |
32 | 臨床試驗與研究計畫,DMR100-IRB-006,,附醫廠商計畫,一項第II期、開放性試驗,針對曾經接受雄性素去除 (androgen deprivation)及背景化學藥物Docetaxel治療法失敗的晚期攝護腺癌病患,探討使用JNJ-212082 (Abiraterone Acetate)倂用Prednisolone的功效,2016.1.1~2016.12.31 | 2016 . 01 |
33 | 臨床試驗與研究計畫,CMUH105-REC2-091,葉士芃(Su-Peng Yeh)、林精湛(Ching-Chan Lin)、楊啟瑞(Che-Rei Yang)、吳錫金(Wu,Hsi-Chin)、陳冠亨(Guang-Heng Chen)、黃志平(Chi-Ping Huang),附醫廠商計畫,針對罹患局部晚期或轉移之泌尿上皮癌,完成第一線含鉑化學治療後無疾病惡化之患者,比較接受維持性治療Avelumab* (MSB0010718C)合併最佳支持性照護或單獨最佳支持性照護的一項第三期、多中心、多國、隨機分配、開放性、平行組別試驗,2016.1.1~2016.12.31 | 2016 . 01 |
34 | 臨床試驗與研究計畫,CMUH105-REC3-093,吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)、葉士芃(Su-Peng Yeh)、林精湛(Ching-Chan Lin)、陳冠亨(Guang-Heng Chen)、謝博帆(Po-Fan Hsieh),附醫廠商計畫,一項第三期、隨機分配、開放性試驗,評估Pembrolizumab(MK-3475)併用Axitinib相較於Sunitinib單一療法做為局部晚期或轉移性腎細胞癌第一線療法的療效和安全性(KEYNOTE-426),2016.1.1~2016.12.31 | 2016 . 01 |
35 | 臨床試驗與研究計畫,CMUH103-REC2-105,張兆祥(Chang,Chao-Hsiang)、葉進仲(Yeh, Chin-Chung)、吳錫金(Wu,Hsi-Chin)、黃志平(Chi-Ping Huang)、陳汶吉(Chen, Wen-Chi),附醫廠商計畫,一項開放性、單組試驗,以評估晚期前列腺癌受試者使用Leuprolide Mesylate注射液(LMIS 50mg)的安全性、療效與藥物動力學型態,2016.1.1~2016.12.31 | 2016 . 01 |
36 | 臨床試驗與研究計畫,DMR99-IRB-243,,附醫廠商計畫,一項針對在docetaxel基礎治療時或之後發生惡化的轉移性、去勢治療無效之前列腺癌患者,比較Orteronel (TAK-700)併用Prednisone以及安慰劑併用Prednisone的第三期、隨機分配、雙盲、多中心試驗,2016.1.1~2016.12.31 | 2016 . 01 |
37 | 臨床試驗與研究計畫,DMR99-IRB-093,,附醫廠商計畫,於生殖腺功能不足症患者投予Androgel治療52週之有效性及安全性臨床試驗,2016.1.1~2016.12.31 | 2016 . 01 |
38 | 臨床試驗與研究計畫,DMR99-IRB-057,,附醫廠商計畫,一項評估P azopanib 對照S unitinib 用於治療局部晚期&./或轉移性腎細胞癌亞洲患者之療效及安全性試驗一VEG 108844 之附屬研究。,2016.1.1~2016.12.31 | 2016 . 01 |
39 | 臨床試驗與研究計畫,CMUH102-REC2-089,,附醫廠商計畫,一項多中心、隨機分配、雙盲、安慰劑對照、第三期有關ARN-509用於男性患有非轉移性(M0)抗去勢型前列腺癌的研究,2016.1.1~2016.12.31 | 2016 . 01 |
40 | 臨床試驗與研究計畫,DMR99-IRB-249,,附醫廠商計畫,一項針對未曾接受化療、轉移性、去勢治療無效的前列腺癌患者,比較Orteronel (TAK-700)併用Prednisone以及安慰劑併用Prednisone的第三期、隨機分配、雙盲、多中心試驗,2016.1.1~2016.12.31 | 2016 . 01 |
41 | 臨床試驗與研究計畫,CMUH103-REC1-126,林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang),附醫廠商計畫,一項第三期、開放標示、多中心、隨機分配之臨床試驗,比較MPDL3280A(抗PD-L1抗體)與化學治療,用於含鉑藥物化學治療無效的局部晚期或轉移性尿路上皮膀胱癌患者之療效及安全性評估,2016.1.1~2016.12.31 | 2016 . 01 |
42 | 臨床試驗與研究計畫,CMUH102-REC1-068,,附醫廠商計畫,PROSPER:在非轉移性去勢抗性前列腺癌病患中評估enzalutamide 療效和安全性的一項多國、第三期、隨機分派、雙盲、安慰劑對照試驗,2016.1.1~2016.12.31 | 2016 . 01 |
43 | 臨床試驗與研究計畫,CMUH102-REC2-059,,附醫廠商計畫,一項針對亞太地區(澳洲、韓國及台灣)抗去勢型前列腺癌(Castrate-Resistant Prostate Cancer, CRPC)並發生骨骼轉移的病患進行之疾病負擔研究,2016.1.1~2016.12.31 | 2016 . 01 |
44 | 臨床試驗與研究計畫,CMUH103-REC1-038,張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、葉進仲(Yeh, Chin-Chung)、陳汶吉(Chen, Wen-Chi)、陳國樑(Chen, Kuo-Liang)、鄒頷龍、黃志平(Chi-Ping Huang),附醫廠商計畫,第二期雙盲隨機分組安慰劑控制臨床試驗研究MCS®於預防男性前列腺癌之效果及安全性,2016.1.1~2016.12.31 | 2016 . 01 |
45 | 臨床試驗與研究計畫,CMUH104-REC2-150,張兆祥(Chang,Chao-Hsiang)、楊啟瑞(Che-Rei Yang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、連啟舜(Chi-Shun Lien)、黃志平(Chi-Ping Huang),附醫廠商計畫,一項第三期隨機研究,針對接受確定性療法後其高風險非轉移性前列腺癌仍惡化的男性患者,探討 Enzalutamide + Leuprolide 療法、Enzalutamide 單一療法及安慰劑 + Leuprolide 療法的療效和安全性,2016.1.1~2016.12.31 | 2016 . 01 |
46 | 臨床試驗與研究計畫,CMUH102-REC1-088,,附醫廠商計畫,一項第III期、隨機、雙盲、安慰劑對照、使用Tasquinimod針對亞洲族群未接受化學治療的轉移性去勢抵抗性前列腺癌患者的臨床試驗,2016.1.1~2016.12.31 | 2016 . 01 |
47 | 個別型,NHRI-EX104-10318PC,洪瑞松(Jui-Sung Hung)、林正介(Cheng-Chieh Lin)、李采娟(Tsai-Chung Li)、吳錫金(Wu,Hsi-Chin)、洪靚娟(Chin-Chuan Hung)、林志學(Chih-Hsueh Lin)、謝右文(Yow-Wen Hsieh)、張欽凱(Chin-Kan Chang)、蔡馨慧、廖俊惠(Chun-Hui Liao)、周哲毅(Che-Yi Chou),國衛院,老年人睡眠障礙使用安眠藥品之風險與效益評估,2015.1.1~2015.12.31 | 2015 . 01 |
48 | 整合型(召集人、總主持人),MOHW103-CMAP-M-212-000301,許重義(Chung Y. Hsu)、周德陽(Der-Yang Cho)、吳錫金(Wu,Hsi-Chin)、謝慶良(Ching-Liang Hsieh)、賴學洲(Hsueh-Chou Lai)、李采娟(Tsai-Chung Li)、陳洋源(Yang-Yuan Chen)、施宜興(Yi-Hsiang Shih)、周仁偉(Jen-Wei Chou)、余承儒(Cheng-Ju Yu)、馮俊龍(Chun-Lung Feng),衛福部,教學醫院成立中藥臨床試驗中心,2014.4.27~2014.12.31 | 2014 . 04 |
49 | 整合型(召集人、總主持人),A1021236,蔡銘修(Ming-Hsui Tsai)、蔡伯邦(Po-Pang Tsai)、彭成元(Cheng-Yuan Peng)、邱昌芳(Chang-Fang Chiu)、謝清昀(Ching-Yun Hsieh)、謝右文(Yow-Wen Hsieh)、葉士芃(Su-Peng Yeh)、花俊宏(Chun-Hung Hua)、楊世能(Shih-Neng Yang)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、許玲女(Ling-Nu Hsu)、葉聯舜(Lian-Shung Yeh)、林維卿(Wei-Ching Lin)、劉秋松(Chiu-Shong Liu)、梁基安(Ji-An Liang)、陳志毅(Chih-Yi Chen)、洪耀欽(Yao-Ching Hung)、吳錫金(Wu,Hsi-Chin)、謝淑惠(Shwn-Huey Shieh)、柯道維(TAO-WEI KE)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、林文元(Wen-Yuan Lin)、白禮源(Li-Yuan Bai)、范淑貞(Shu-Chen Fan)、劉良智(Liu, Liang-Chih)、簡君儒(Chun-Ru Chien)、林智一(Tze-Yi Lin)、廖惠娟(Hui-Chuan Liao),衛福部,103年醫院癌症診療品質提升計畫,2014.1.22~2014.12.31 | 2014 . 01 |
50 | 整合型項下子計畫(主持人),NHRI-EX103-10318PC,林正介(Cheng-Chieh Lin)、李采娟(Tsai-Chung Li)、洪瑞松(Jui-Sung Hung)、吳錫金(Wu,Hsi-Chin)、洪靚娟(Chin-Chuan Hung)、林志學(Chih-Hsueh Lin)、廖俊惠(Chun-Hui Liao)、謝右文(Yow-Wen Hsieh)、張欽凱(Chin-Kan Chang)、周哲毅(Che-Yi Chou)、蔡馨慧(Hsin-hui TSAI),國衛院,老年人睡眠障礙使用安眠藥品之風險與效益評估,2014.1.1~2014.12.31 | 2014 . 01 |
51 | 整合型(召集人、總主持人),102CANCER,陳志毅(Chih-Yi Chen)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、彭成元(Cheng-Yuan Peng)、蔡伯邦(Po-Pang Tsai)、謝清昀(Ching-Yun Hsieh)、謝右文(Yow-Wen Hsieh)、葉士芃(Su-Peng Yeh)、花俊宏(Chun-Hung Hua)、楊世能(Shih-Neng Yang)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、許玲女(Ling-Nu Hsu)、葉聯舜(Lian-Shung Yeh)、何永仁(Yung-Jen Ho)、劉秋松(Chiu-Shong Liu)、梁基安(Ji-An Liang)、洪耀欽(Yao-Ching Hung)、吳錫金(Wu,Hsi-Chin)、謝淑惠(Shwn-Huey Shieh)、柯道維(TAO-WEI KE)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、林文元(Wen-Yuan Lin)、白禮源(Li-Yuan Bai)、葉名焮(Ming-Hsin, Alex, Yeh)、簡君儒(Chun-Ru Chien)、林智一(Tze-Yi Lin)、范淑貞(Shu-Chen Fan),衛福部,102年醫院癌症醫療品質提升計畫,2013.1.1~2013.12.31 | 2013 . 01 |
52 | 國家型,CCMP102-CT-202,許重義(Chung Y. Hsu)、周德陽(Der-Yang Cho)、謝慶良(Ching-Liang Hsieh)、李源德(Yuan-Teh, Lee)、吳錫金(Wu,Hsi-Chin)、賴學洲(Hsueh-Chou Lai)、李采娟(Tsai-Chung Li),衛福部,102年度教學醫院成立中藥臨床試驗中心,2013.1.1~2013.12.31 | 2013 . 01 |
53 | 個別型,DMR-102-048,吳錫金(Wu,Hsi-Chin)、林香汶(Margaret Hsiang-Wen Lin)、楊榮林(Rong-Lin Yang)、許玲女(Ling-Nu Hsu)、謝右文(Yow-Wen Hsieh),附醫院內計畫,使用智能型單一劑量藥車對住院給藥及病患照護的影響,2012.8.1~2013.7.31 | 2012 . 08 |
54 | 整合型(召集人、總主持人),CCMP101-CT-202,許重義(Chung Y. Hsu)、周德陽(Der-Yang Cho)、謝慶良(Ching-Liang Hsieh)、李源德(Yuan-Teh, Lee)、吳錫金(Wu,Hsi-Chin)、劉崇祥(Chung-Hsiang Liu)、李采娟(Tsai-Chung Li),衛福部,101年度教學醫院成立中藥臨床試驗中心,2012.1.1~2012.12.31 | 2012 . 01 |
55 | 個別型,101suicide,吳錫金(Wu,Hsi-Chin)、藍先元(Hsien-Yuan Lane)、廖俊惠(Chun-Hui Liao)、王明鈺(Mingyu-Yu Wang)、黃秋錦(Chiu-Ching Huang)、邱昌芳(Chang-Fang Chiu)、徐武輝(Wu-Huei Hsu)、許玲女(Ling-Nu Hsu)、徐逸民(Yi-Min Hsu)、劉秋松(Chiu-Shong Liu),衛福部,100年度「醫院試辦老人自殺防治品質促進計畫」,2011.12.29~2012.12.29 | 2011 . 12 |
56 | 國家型,CCMP100-CT-202,周德陽(Der-Yang Cho)、謝慶良(Ching-Liang Hsieh)、李源德(Yuan-Teh, Lee)、吳錫金(Wu,Hsi-Chin)、劉崇祥(Chung-Hsiang Liu)、李采娟(Tsai-Chung Li),衛福部,100年度教學醫院成立中藥臨床試驗中心,2011.1.1~2011.12.31 | 2011 . 01 |
57 | 個別型,NSC 99-2320-B-039-036,吳錫金(Wu,Hsi-Chin)、林則彬(Tzer-Bin Lin),科技部,探討AMPA接受器的移動和磷酸化參予跨臟器敏化作用,2010.9.1~2011.7.31 | 2010 . 09 |
58 | 個別型,CMU98-N2-03,吳錫金(Wu,Hsi-Chin)、陳國樑(Chen, Kuo-Liang),本校(含附醫),低劑量PYRROLIDINE DITHIOCARBAMATE/CU COMPLEX經由粒線體和內質網壓力路徑誘導肺臟肺泡上皮細胞凋亡,2010.4.1~2011.3.31 | 2010 . 04 |
59 | 國家型,CCMP99-CT-201,周德陽(Der-Yang Cho)、謝慶良(Ching-Liang Hsieh)、李源德(Yuan-Teh, Lee)、吳錫金(Wu,Hsi-Chin)、劉崇祥(Chung-Hsiang Liu)、李采娟(Tsai-Chung Li),衛福部,99年度教學醫院成立中藥臨床試驗中心,2010.1.1~2010.12.31 | 2010 . 01 |
60 | 國家型,MOE-98-03-03-2-21-3-10,辛幸珍(Hsin-Chen Hsin)、戴志展(Chih-Jaan Tai)、許儷絹(Li-Chuan Hsu),,以PBL理念貫穿「生命」、「人我」、「醫病」三階概念之醫學倫理教學課程,2009.8.1~2010.9.30 | 2009 . 08 |
61 | 個別型,DMR-97-065,張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin),附醫院內計畫,年輕女性不同排尿姿勢對尿流速與餘尿的影響,2007.8.1~2008.7.31 | 2007 . 08 |
62 | 個別型,CMU95-207,林綽娟(Lin,Chouh-Jiuan)、吳錫金(Wu,His-Chin)、張兆祥(Chang,Chao-Hsian)、鄒頡龍,本校(含附醫),婦女非坐式使用公廁坐式馬桶與其排尿之關係研究,2006.8.1~2007.7.31 | 2006 . 08 |
63 | 個別型,DOH-BHP-95-01,彭慶添(Peng,Ching-Tien)、鄭隆賓(Jeng,Long-Bin)、吳錫金(Wu,His-Chin)、邱昌芳(Chiu,Chang-Fang)、許南榮(Hsu,Nan-Yung)、蔡銘修(Tsai,Ming-Hsui)、張兆祥(Chang,Chao-Hsian)、周德陽(Cho,Der-Yang)、夏德椿(Hsia,Te-Chun)、洪耀欽,衛福部,95-96年度安寧共同照護計畫,2006.1.1~2007.12.31 | 2006 . 01 |
64 | 個別型,NSC94-2314-B-468-002,蔡文正(Tsai,Wen-Chen)、吳錫金(Wu,His-Chin),科技部,影響高科技醫療利用相關因素-以體外震波碎石術(ESWL)為例,2005.8.1~2006.7.31 | 2005 . 08 |
65 | 個別型,DMR-95-053,吳錫金(Hsi-Chin Wu),本校(含附醫),以周邊血液重建陰莖海綿體組織之研究,2005.7.1~2006.6.30 | 2005 . 07 |
66 | 個別型,DMR-95-055,孟乃欣(Nai-Hsin Meng)、楊佩瑜(Pei-Yu Yang)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin),附醫院內計畫,智能障礙孩童的排尿障礙,2005.7.1~2006.6.30 | 2005 . 07 |
67 | 個別型,DMR-95-054,張兆祥(Chao-Hsiang Chang),本校(含附醫),局限性攝護腺癌治療的生活品質評估:以歐洲癌症治療與研究組織生活品質核心問卷及攝護腺癌生活品質問卷評估,2005.7.1~2006.6.30 | 2005 . 07 |
68 | 個別型,DOH-BHP-94-03,彭慶添(Peng,Ching-Tien)、鄭隆賓(Jeng,Long-Bin)、陳志毅、吳錫金(Wu,His-Chin)、邱昌芳(Chiu,Chang-Fang)、許南榮(Hsu,Nan-Yung)、蔡銘修(Tsai,Ming-Hsui)、張兆祥(Chang,Chao-Hsian)、周德陽(Cho,Der-Yang)、夏德椿(Hsia,Te-Chun),衛福部,九十四年度安寧共同照護計畫,2005.1.1~2005.12.31 | 2005 . 01 |
專利技術
暫無資料獲獎事蹟
獲獎/Award (獲獎名稱,給獎單位,獲獎日期) |
日期 | |
1 | 台灣醫學教育學會最佳醫學論文獎,台灣醫學教育學會,2015.10.31 | 2015 . 10 |
2 | Second Prize in the CURy Best Abstract Award,The 3rd World Congress on Controversies in Urology (CURy),2010.2.27 | 2010 . 02 |